syndrome	score	normalized_score
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	1.100843882	100.0
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.02309351	92.93720269773912
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	1.0212766	92.77215567974606
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0188679	92.55335081200914
BARTH SYNDROME; BTHS	1.00990099	91.73880206930195
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	1.00900901	91.65777513945433
SENGERS SYNDROME	1.00900901	91.65777513945433
OCULOSKELETODENTAL SYNDROME; OCSKD	1.002785632	91.09244720315391
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.002785632	91.09244720315391
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.00194175	91.01578946686648
YOU-HOOVER-FONG SYNDROME; YHFS	1.000843882	90.91605979420795
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	1.0	90.83940205792051
BUTYRYLCHOLINESTERASE	1.0	90.83940205792051
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	1.0	90.83940205792051
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	1.0	90.83940205792051
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	1.0	90.83940205792051
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.958333	87.05439669237313
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.8431858919999999	76.59450225295433
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.5297616	48.12322697724727
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.516496162	46.918202521290844
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.509852892	46.31473184678152
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.50210084	45.61054007837962
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.500843882	45.4963587652477
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.500843882	45.4963587652477
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5	45.419701028960255
RENAL TUBULAR ACIDOSIS III	0.5	45.419701028960255
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	45.419701028960255
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.4069415	36.96632253255326
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.375	34.06477577172019
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.34945611000000004	31.7443840778869
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.336118632	30.532815551406223
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.334176882	30.356428142460263
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	30.27977040617282
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.333333	30.27977040617282
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	30.27977040617282
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.333333	30.27977040617282
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.291667	26.4948558800275
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.291667	26.4948558800275
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.291667	26.4948558800275
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.26755602	24.30462887379702
#602398 DESMOSTEROLOSIS	0.261512332	23.755623869652393
OROFACIODIGITAL SYNDROME I; OFD1	0.25551381	23.21072171794111
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.25551381	23.21072171794111
ALPHA-METHYLACETOACETIC ACIDURIA	0.25	22.709850514480127
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.25	22.709850514480127
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.25	22.709850514480127
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.25	22.709850514480127
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.25	22.709850514480127
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.23527505	21.37224486114735
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.20194175	18.34426782053007
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.20194175	18.34426782053007
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.200843882	18.244538147871545
#613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	0.2	18.167880411584104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17521401	15.916335900570505
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.17486372	15.884515766423638
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.17410699999999998	15.815775774098364
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.17410699999999998	15.815775774098364
ARTERIAL TORTUOSITY SYNDROME	0.17007997	15.449962776829059
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.16961172200000002	15.407427408494243
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.167510882	15.216588359074882
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.166667	15.139930622787439
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.166667	15.139930622787439
STORMORKEN SYNDROME; STRMK	0.166667	15.139930622787439
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.166667	15.139930622787439
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.16318158200000002	14.823317335745525
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.15694149999999998	14.25647201807313
GALACTOSEMIA	0.15694149999999998	14.25647201807313
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.15694149999999998	14.25647201807313
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.14763151	13.410758093307912
PYRUVATE CARBOXYLASE DEFICIENCY	0.143399902	13.026361352844399
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.14285699999999998	12.97704445978835
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.14285699999999998	12.97704445978835
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.14285699999999998	12.97704445978835
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.14285699999999998	12.97704445978835
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.14285699999999998	12.97704445978835
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.14285699999999998	12.97704445978835
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.14285699999999998	12.97704445978835
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.14285699999999998	12.97704445978835
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.139928382	12.711010551812288
LOWE OCULOCEREBRORENAL SYNDROME	0.13513847	12.275897809822231
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.13490099	12.254325268621514
OCULOECTODERMAL SYNDROME; OES	0.125843882	11.431582993527504
SAY SYNDROME	0.125	11.354925257240064
Fabry disease	0.125	11.354925257240064
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.125	11.354925257240064
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.125	11.354925257240064
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.12339350200000002	11.20899193951282
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.12181262200000001	11.065385745587495
GLYCEROL KINASE DEFICIENCY; GKD	0.107938322	9.805052629615286
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.10583748200000001	9.614213580195926
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.10583748200000001	9.614213580195926
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.10295062200000002	9.351972943970999
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.10295062200000002	9.351972943970999
VICI SYNDROME; VICIS	0.102944722	9.351436991498856
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.100299992	9.111191299694212
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.1	9.083940205792052
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.1	9.083940205792052
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.1	9.083940205792052
ALAGILLE SYNDROME 1; ALGS1	0.1	9.083940205792052
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.1	9.083940205792052
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.1	9.083940205792052
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.1	9.083940205792052
TIGLIC ACIDEMIA	0.1	9.083940205792052
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.1	9.083940205792052
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.09985845	9.071081888430752
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.09985845	9.071081888430752
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.09985845	9.071081888430752
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.09518322200000001	8.646386972426306
KOOLEN-DE VRIES SYNDROME; KDVS	0.09308213200000001	8.45552521315643
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.09175298200000001	8.334786021911144
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.09175298200000001	8.334786021911144
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0909091	8.258128285623702
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0909091	8.258128285623702
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.089828502	8.159967409438718
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.08422272	7.6507415244916634
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.083142082	7.552577014730597
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.082803692	7.521837869468216
KEARNS-SAYRE SYNDROME; KSS	0.07997561	7.264936591617449
ERYTHERMALGIA, PRIMARY	0.07969622	7.239556971076485
HEART AND BRAIN MALFORMATION SYNDROME	0.07952796200000002	7.224272514965026
BOHRING-OPITZ SYNDROME	0.07952796200000002	7.224272514965026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.07568545200000001	6.875221204163445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.07568545200000001	6.875221204163445
SWEENEY-COX SYNDROME; SWCOS	0.07437332200000002	6.7560280995411865
ADENYLOSUCCINASE DEFICIENCY	0.07437332200000002	6.7560280995411865
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.07437332200000002	6.7560280995411865
Orofaciodigital syndrome XVII	0.07352944000000002	6.679370363253745
MEIER-GORLIN SYNDROME 5; MGORS5	0.07352944000000002	6.679370363253745
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.07337035000000001	6.6649187227803495
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.072649572	6.599443680243844
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.07227248200000001	6.565189050121824
ALAGILLE SYNDROME 2	0.07142860000000001	6.4885313138343825
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.07142860000000001	6.4885313138343825
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.07142860000000001	6.4885313138343825
BECKWITH-WIEDEMANN SYNDROME	0.07142860000000001	6.4885313138343825
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.07142860000000001	6.4885313138343825
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.07142860000000001	6.4885313138343825
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.07142860000000001	6.4885313138343825
WILLIAMS-BEUREN SYNDROME; WBS	0.07010142000000001	6.367971076211151
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.06945233199999999	6.309008310408178
HYDROXYKYNURENINURIA	0.06755998199999999	6.137108367923872
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.067510582	6.132620901462212
DYSTONIA 28, CHILDHOOD-ONSET	0.067510582	6.132620901462212
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.0666667	6.055963165174769
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.0666667	6.055963165174769
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.0666667	6.055963165174769
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.0666667	6.055963165174769
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.0666667	6.055963165174769
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.0666667	6.055963165174769
KABUKI SYNDROME 1	0.06283127200000001	5.707555179018565
PITT-HOPKINS SYNDROME	0.06039792	5.486510938342119
SILVER-RUSSELL SYNDROME; SRS	0.059713582	5.424346083616605
ROIFMAN SYNDROME; RFMN	0.059147852	5.372955508690378
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	5.347688347329163
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	5.2077684163393485
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.05732667	5.20752042477173
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.05671323	5.15179590197332
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.05457335	4.957410482297616
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.053475482	4.857680809639091
NETHERTON SYNDROME; NETH	0.053475482	4.857680809639091
THROMBOCYTOPENIA 1	0.0526316	4.781023073351649
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0526316	4.781023073351649
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.0526316	4.781023073351649
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0526316	4.781023073351649
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0526316	4.781023073351649
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0526316	4.781023073351649
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0526316	4.781023073351649
ROWLEY-ROSENBERG SYNDROME	0.0526316	4.781023073351649
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0526316	4.781023073351649
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0526316	4.781023073351649
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0526316	4.781023073351649
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.0526316	4.781023073351649
CRAMPS, FAMILIAL ADOLESCENT	0.0526316	4.781023073351649
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.050691882	4.604820250070664
ACRORENAL-MANDIBULAR SYNDROME	0.049129950000000006	4.462935281135532
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.049129950000000006	4.462935281135532
AU-KLINE SYNDROME; AUKS	0.048878121999999996	4.44005937619409
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.047936882	4.354557697401093
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.04783416	4.345226492342899
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.045995132	4.178170288455125
WITTEVEEN-KOLK SYNDROME	0.045474702	4.130894738442122
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044905882	4.0792234697635354
POTOCKI-LUPSKI SYNDROME	0.044660102	4.05689696152574
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.044345591999999996	4.028327061184503
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.04347177	3.9489495931994476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.04323429	3.9273770519987323
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.043186192	3.92300785843855
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.043050410000000004	3.910673502748322
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.043050410000000004	3.910673502748322
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.043050410000000004	3.910673502748322
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.042782242	3.886313281977253
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.04267952	3.8769820769190595
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.042582162	3.868138134413505
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.042385392	3.8502636652705675
JOHANSON-BLIZZARD SYNDROME; JBS	0.041684799999999994	3.7866223069040044
BARAITSER-WINTER SYNDROME 1; BRWS1	0.041509152	3.7706665476113352
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.041406222	3.7613164479575136
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.04115099	3.7381313256914663
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.040908942	3.7161438301021503
CHROMOSOME 5Q12 DELETION SYNDROME	0.040481322	3.677299084994143
COWDEN SYNDROME 6; CWS6	0.04040325	3.6702070711966774
COWDEN SYNDROME 5; CWS5	0.04040325	3.6702070711966774
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.03927337	3.5675694475994737
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.03847239	3.4948089033391208
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.03847239	3.4948089033391208
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	3.49381966225071
BETHLEM MYOPATHY 1	0.0384615	3.49381966225071
THUMB DEFORMITY	0.0384615	3.49381966225071
ATROPHODERMA VERMICULATA; AVA	0.0384615	3.49381966225071
PREPAPILLARY VASCULAR LOOPS	0.0384615	3.49381966225071
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	3.49381966225071
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	3.49381966225071
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	3.49381966225071
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	3.49381966225071
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	3.49381966225071
MUSCULAR HYPERTONIA, LETHAL	0.0384615	3.49381966225071
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	3.49381966225071
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	3.49381966225071
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	3.49381966225071
WATSON SYNDROME	0.0384615	3.49381966225071
ARTERIES, ANOMALIES OF	0.0384615	3.49381966225071
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0377358	3.4278975081772765
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.037427522000000005	3.399893718989665
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.037427522000000005	3.399893718989665
#300867 KABUKI SYNDROME 2; KABUK2	0.037427522000000005	3.399893718989665
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.037427522000000005	3.399893718989665
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.037118410000000004	3.3718141697407376
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.03658364	3.323235982702223
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.036278022	3.295473826324086
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.03606048	3.275712441121601
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.0358604	3.257537293557853
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.035744882	3.2470437075109255
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.035326682	3.2090546695703033
KBG SYNDROME	0.035326682	3.2090546695703033
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.035326682	3.2090546695703033
MENTAL RETARDATION, X-LINKED 9	0.035326682	3.2090546695703033
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.035326682	3.2090546695703033
NEMALINE MYOPATHY 2; NEM2	0.03529259	3.2059577726753448
NIJMEGEN BREAKAGE SYNDROME	0.034901	3.1703859712234843
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.03466297	3.148763468351637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0344927	3.133296243363235
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0344828	3.132396933282861
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.0344828	3.132396933282861
BARAITSER-WINTER SYNDROME 2; BRWS2	0.0344828	3.132396933282861
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0344828	3.132396933282861
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0344828	3.132396933282861
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.034177182	3.1046347769047236
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.034177182	3.1046347769047236
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.034177182	3.1046347769047236
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.034177182	3.1046347769047236
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.034177182	3.1046347769047236
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.034177182	3.1046347769047236
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.034177182	3.1046347769047236
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.034177182	3.1046347769047236
SPINOCEREBELLAR ATAXIA 5; SCA5	0.034177182	3.1046347769047236
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0333333	3.0279770406172823
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.0333333	3.0279770406172823
HUNTINGTON DISEASE-LIKE 1	0.0333333	3.0279770406172823
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0333333	3.0279770406172823
ORAL SENSIBILITY, DISTURBANCE OF	0.0333333	3.0279770406172823
Adrenoleukodystrophy	0.0333333	3.0279770406172823
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.0333333	3.0279770406172823
SPINOCEREBELLAR ATAXIA 26	0.0333333	3.0279770406172823
EPISODIC ATAXIA, TYPE 1; EA1	0.0333333	3.0279770406172823
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0333333	3.0279770406172823
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0333333	3.0279770406172823
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.0333333	3.0279770406172823
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.03319175	3.0151187232559833
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.03319175	3.0151187232559833
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.03319175	3.0151187232559833
NEMALINE MYOPATHY 3; NEM3	0.03319175	3.0151187232559833
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.0330184	2.999371712909243
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.032484402	2.950863653889117
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.032484402	2.950863653889117
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.032321982	2.9361095182068695
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.032093882	2.915389050597458
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.031920532	2.8996420402507175
COSTELLO SYNDROME; CSTLO	0.031920532	2.8996420402507175
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.031920532	2.8996420402507175
PROPIONIC ACIDEMIA	0.031672112	2.8770757159914893
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.031672112	2.8770757159914893
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.03164052	2.874205917601675
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.031549641999999996	2.8659506144214553
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.031357032	2.8484540371910794
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.031321472	2.8452237880539
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03125	2.838731314310016
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.03125	2.838731314310016
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.03125	2.838731314310016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.03125	2.838731314310016
HYPEREKPLEXIA 1; HKPX1	0.03125	2.838731314310016
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.03125	2.838731314310016
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.03125	2.838731314310016
SPINOCEREBELLAR ATAXIA 37; SCA37	0.03125	2.838731314310016
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.03125	2.838731314310016
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.03125	2.838731314310016
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.03125	2.838731314310016
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.03125	2.838731314310016
STIFF-PERSON SYNDROME; SPS	0.03125	2.838731314310016
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.03125	2.838731314310016
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.03125	2.838731314310016
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.03125	2.838731314310016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.03125	2.838731314310016
SPINOCEREBELLAR ATAXIA 44; SCA44	0.03125	2.838731314310016
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.03125	2.838731314310016
ROBERTS SYNDROME; RBS	0.031076649999999997	2.8229843039632754
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.030581382	2.7779944549848534
MOWAT-WILSON SYNDROME; MOWS	0.03047759	2.7685660517664576
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.03034899	2.7568841046618093
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.030242642	2.7472235159317533
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.029850252	2.7115790429582463
ANGELMAN SYNDROME	0.029850252	2.7115790429582463
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.029799092	2.7069316991489627
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.029448801999999996	2.6751115650020934
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.029448801999999996	2.6751115650020934
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.029415282	2.672066628245112
CITRULLINEMIA, CLASSIC	0.029415282	2.672066628245112
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.029415282	2.672066628245112
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.028919212	2.6270039260662394
PETERS-PLUS SYNDROME; PTRPLS	0.028909011999999998	2.6260773641652486
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02860492	2.5984538287146517
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.0285714	2.5954088919576703
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.0285714	2.5954088919576703
WOLFF-PARKINSON-WHITE SYNDROME	0.0285714	2.5954088919576703
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0285714	2.5954088919576703
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0285714	2.5954088919576703
PSEUDOXANTHOMA ELASTICUM; PXE	0.0285714	2.5954088919576703
SICKLE CELL ANEMIA	0.0285714	2.5954088919576703
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0285714	2.5954088919576703
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0285714	2.5954088919576703
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.0285714	2.5954088919576703
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.0285714	2.5954088919576703
SNEDDON SYNDROME	0.0285714	2.5954088919576703
Polyarteritis nodosa, childhood-onset	0.0285714	2.5954088919576703
AMYLOIDOSIS VI	0.0285714	2.5954088919576703
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0285714	2.5954088919576703
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	0.0285714	2.5954088919576703
STROKE, ISCHEMIC	0.0285714	2.5954088919576703
DERMOGRAPHISM, FAMILIAL	0.0285714	2.5954088919576703
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.0285714	2.5954088919576703
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0285714	2.5954088919576703
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0285714	2.5954088919576703
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0285714	2.5954088919576703
CARDIOMYOPATHY, DILATED, 1E	0.0285714	2.5954088919576703
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.0285714	2.5954088919576703
TYSHCHENKO SYNDROME	0.028507562	2.5896098862090966
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.028507562	2.5896098862090966
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.028300892	2.5708361069857864
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.027908502	2.535191634012279
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.027908502	2.535191634012279
Glycosylphosphatidylinositol biosynthesis defect 18	0.027908502	2.535191634012279
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.027663679999999996	2.512952149921654
Mulchandani-Bhoj-Conlin syndrome	0.02750459	2.49850050944826
TEMPLE SYNDROME	0.027504589999999995	2.4985005094482595
CHROMOSOME 19p13.13 DELETION SYNDROME	0.026946372000000003	2.4477923201102922
Pierpont syndrome	0.026808171999999998	2.435238314745887
NOONAN SYNDROME 6; NS6	0.026765892	2.4313976248268783
Retinitis pigmentosa with or without skeletal anomalies	0.026765892	2.4313976248268783
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.026596622	2.4160212392405342
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.026206282	2.380562987041245
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02592201	2.3547398885394357
#611554 LEOPARD SYNDROME 2	0.02592201	2.3547398885394357
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.025879142	2.3508457850520172
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.025762919999999998	2.3402882480660416
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.025562839999999996	2.3221131005022926
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.025333711999999998	2.3012992499875655
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.025294671999999997	2.297752879731224
AGNATHIA-OTOCEPHALY COMPLEX	0.02468957	2.2427857758671723
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.024489829999999997	2.224641513700123
COFFIN-LOWRY SYNDROME; CLS	0.02422262	2.2003683170762267
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.02422262	2.2003683170762267
#614976 CARPENTER SYNDROME 2; CRPT2	0.024221322	2.200250407532355
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.02382117	2.1639008391200742
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.02382117	2.1639008391200742
SMITH-KINGSMORE SYNDROME; SKS	0.02382117	2.1639008391200742
Diamond-Blackfan anemia 1	0.02382117	2.1639008391200742
LEGIUS SYNDROME	0.02382117	2.1639008391200742
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.023475392	2.1324905723552905
FUMARASE DEFICIENCY; FMRD	0.023475392	2.1324905723552905
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.023475392	2.1324905723552905
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.023475392	2.1324905723552905
HYPOGLOSSIA WITH SITUS INVERSUS	0.02337744	2.1235926712449134
MARFANOID HABITUS WITH SITUS INVERSUS	0.02321835	2.1091410307715184
RENPENNING SYNDROME 1; RENS1	0.02321835	2.1091410307715184
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.023193831999999998	2.1069138303118624
Helsmoortel-van der Aa syndrome	0.023124752000000002	2.1006386444177014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.023093509999999998	2.0978006398186078
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.023093509999999998	2.0978006398186078
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.023093509999999998	2.0978006398186078
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.023093509999999998	2.0978006398186078
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.023093509999999998	2.0978006398186078
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.023093509999999998	2.0978006398186078
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.023093509999999998	2.0978006398186078
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.023023222	2.091415719926761
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	2.0847215827103085
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	2.0847215827103085
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	2.0847215827103085
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	2.0847215827103085
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	2.0847215827103085
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.02263151	2.055832836067849
#610773 MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY;;MPCD	0.02263151	2.055832836067849
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02263151	2.055832836067849
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	0.02263151	2.055832836067849
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.022592162	2.0522584872756733
RESTRICTIVE DERMOPATHY, LETHAL	0.022509039999999998	2.044707734497815
YUNIS-VARON SYNDROME	0.022509039999999998	2.044707734497815
KNIEST-LIKE DYSPLASIA, LETHAL	0.022509039999999998	2.044707734497815
GAUCHER DISEASE, PERINATAL LETHAL	0.022509039999999998	2.044707734497815
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.022381932	2.033161319781037
BARDET-BIEDL SYNDROME 8; BBS8	0.022120482	2.0094113581129935
BARDET-BIEDL SYNDROME 17; BBS17	0.022120482	2.0094113581129935
SECKEL SYNDROME 1; SCKL1	0.02194836	1.99377589855198
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.021851952	1.9850182534783805
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.021820359999999997	1.982148455088566
TURNPENNY-FRY SYNDROME; TPFS	0.021812622	1.981445539795442
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.021748280000000002	1.9756007509882316
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.021653532	1.9669938993220475
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.021653532	1.9669938993220475
CHROMOSOME 1P36 DELETION SYNDROME	0.021650802000000004	1.9667459077544298
611961 STEVENSON-CAREY SYNDROME	0.021650801999999997	1.9667459077544291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.021614472000000003	1.9634457122776654
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.021614472000000003	1.9634457122776654
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.0212766	1.9327536218255514
#614844 NEPHRONOPHTHISIS 14; NPHP14JOUBERT SYNDROME 19, INCLUDED; JBTS19, INCLUDED	0.0212766	1.9327536218255514
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.0212766	1.9327536218255514
#612444 CILIARY DYSKINESIA, PRIMARY, 9; CILD9;;CILIARY DYSKINESIA, PRIMARY, 9, WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.0212766	1.9327536218255514
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0212766	1.9327536218255514
HETEROTAXY, VISCERAL, 2, AUTOSOMAL	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 23; CILD23	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 28; CILD28	0.0212766	1.9327536218255514
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 26; CILD26	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.0212766	1.9327536218255514
#613807 CILIARY DYSKINESIA, PRIMARY, 14; CILD14;;CILIARY DYSKINESIA, PRIMARY, 14, WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
#608644 CILIARY DYSKINESIA, PRIMARY, 3; CILD3;;CILIARY DYSKINESIA, PRIMARY, 3, WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
#613808 CILIARY DYSKINESIA, PRIMARY, 15; CILD15;;CILIARY DYSKINESIA, PRIMARY, 15, WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 25; CILD25	0.0212766	1.9327536218255514
#613193 CILIARY DYSKINESIA, PRIMARY, 13; CILD13;;CILIARY DYSKINESIA, PRIMARY, 13, WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.0212766	1.9327536218255514
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.0212766	1.9327536218255514
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.0212766	1.9327536218255514
POLYCYSTIC KIDNEY DISEASE 2	0.0212766	1.9327536218255514
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 16; CILD16	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 19; CILD19	0.0212766	1.9327536218255514
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 22; CILD22	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0212766	1.9327536218255514
#612518 CILIARY DYSKINESIA, PRIMARY, 10; CILD10	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0212766	1.9327536218255514
#615382 NEPHRONOPHTHISIS 16; NPHP16	0.0212766	1.9327536218255514
#614874 CILIARY DYSKINESIA, PRIMARY, 18; CILD18;;CILIARY DYSKINESIA, PRIMARY, 18, WITH OR WITHOUT SITUS INVERSUS	0.0212766	1.9327536218255514
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.0212766	1.9327536218255514
CILIARY DYSKINESIA, PRIMARY, 40; CILD40	0.0212766	1.9327536218255514
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.021252082	1.9305264213658955
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.021252082	1.9305264213658955
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021252082	1.9305264213658955
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.021252082	1.9305264213658955
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.021252082	1.9305264213658955
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.021252082	1.9305264213658955
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.021252082	1.9305264213658955
KAGAMI-OGATA SYNDROME	0.021252082	1.9305264213658955
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.021252082	1.9305264213658955
INFANTILE SIALIC ACID STORAGE DISEASE	0.021252082	1.9305264213658955
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.021252082	1.9305264213658955
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.021252082	1.9305264213658955
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.021252082	1.9305264213658955
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.021252082	1.9305264213658955
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.021008069999999997	1.908360517190938
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.02096874	1.9047878035080001
CORNELIA DE LANGE SYNDROME 1	0.02096874	1.9047878035080001
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.02096874	1.9047878035080001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.020883342	1.897030300251058
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.020850492	1.8940462258934552
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02080965	1.8903361630346054
MORQUIO SYNDROME A	0.02080965	1.8903361630346054
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.02080965	1.8903361630346054
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02080965	1.8903361630346054
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.02080965	1.8903361630346054
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.02080965	1.8903361630346054
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02080965	1.8903361630346054
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.02080965	1.8903361630346054
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.02080965	1.8903361630346054
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.02080692	1.8900881714669873
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.020722492000000002	1.8824187824300416
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.020722492000000002	1.8824187824300416
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02067527	1.8781291641860622
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.020500742000000002	1.8622751450236976
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.020500742000000002	1.8622751450236976
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.8538686850784531
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.020408199999999998	1.8538686850784531
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.020408199999999998	1.8538686850784531
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	1.8538686850784531
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.020408199999999998	1.8538686850784531
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.020408199999999998	1.8538686850784531
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.020408199999999998	1.8538686850784531
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.8538686850784531
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.020408199999999998	1.8538686850784531
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.8538686850784531
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.020408199999999998	1.8538686850784531
NEUROFIBROMATOSIS, TYPE II	0.020408199999999998	1.8538686850784531
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	1.8538686850784531
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.020408199999999998	1.8538686850784531
FANCONI ANEMIA	0.020408199999999998	1.8538686850784531
NEMALINE MYOPATHY 10	0.020408199999999998	1.8538686850784531
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.8538686850784531
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.8538686850784531
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.020408199999999998	1.8538686850784531
BLOOM SYNDROME	0.020408199999999998	1.8538686850784531
TUBEROUS SCLEROSIS 2; TSC2	0.020408199999999998	1.8538686850784531
NF1-microdeletion syndrome	0.020408199999999998	1.8538686850784531
PHEOCHROMOCYTOMA	0.020408199999999998	1.8538686850784531
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.8538686850784531
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.020408199999999998	1.8538686850784531
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.8538686850784531
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.8538686850784531
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.020408199999999998	1.8538686850784531
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	1.8538686850784531
RUSSELL-SILVER SYNDROME, X-LINKED	0.020408199999999998	1.8538686850784531
TUBEROUS SCLEROSIS	0.020408199999999998	1.8538686850784531
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.8538686850784531
#162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL;;FSNF	0.020408199999999998	1.8538686850784531
GASTROCUTANEOUS SYNDROME	0.020408199999999998	1.8538686850784531
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.8538686850784531
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	1.8538686850784531
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.020377712	1.8510991733885114
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.020260492	1.8404509786792822
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.020260492	1.8404509786792822
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.019878609999999998	1.805761046142599
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.019753882	1.794430829202719
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.019711782	1.7906064903760806
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.019711782	1.7906064903760806
MEHMO SYNDROME; MEHMO	0.019711782	1.7906064903760806
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.019711782	1.7906064903760806
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.019711782	1.7906064903760806
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.019711782	1.7906064903760806
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.019711782	1.7906064903760806
COFFIN-SIRIS SYNDROME 7; CSS7	0.019709051999999998	1.7903584988084622
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.019656859999999998	1.7856174087362553
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.019549961999999997	1.7759068583350677
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.019379272	1.7604014807978012
CERVICAL RIB	0.0188679	1.7139487540886382
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.7139487540886382
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0188679	1.7139487540886382
AMELOGENESIS IMPERFECTA, TYPE IJ	0.0188679	1.7139487540886382
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.7139487540886382
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.7139487540886382
MYOPATHY, CONGENITAL	0.0188679	1.7139487540886382
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.7139487540886382
PALMOMENTAL REFLEX	0.0188679	1.7139487540886382
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.7139487540886382
OHDO SYNDROME	0.0188679	1.7139487540886382
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.7139487540886382
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.7139487540886382
RHEUMATOID ARTHRITIS	0.0188679	1.7139487540886382
CRANIOECTODERMAL DYSPLASIA 1	0.0188679	1.7139487540886382
CRANIOECTODERMAL DYSPLASIA 3	0.0188679	1.7139487540886382
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.7139487540886382
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0188679	1.7139487540886382
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.0188679	1.7139487540886382
269800 SENILE PLAQUE FORMATION	0.0188679	1.7139487540886382
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.7139487540886382
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.7139487540886382
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.7139487540886382
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.0188679	1.7139487540886382
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.7139487540886382
ZUNICH NEUROECTODERMAL SYNDROME	0.0188679	1.7139487540886382
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.7139487540886382
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0188679	1.7139487540886382
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.7139487540886382
THUMBS, CONGENITAL CLASPED	0.0188679	1.7139487540886382
DIASTEMATOMYELIA	0.0188679	1.7139487540886382
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.7139487540886382
CARDIAC ARRHYTHMIA	0.0188679	1.7139487540886382
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.7139487540886382
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.7139487540886382
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.7139487540886382
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.7139487540886382
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.7139487540886382
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0188679	1.7139487540886382
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.7139487540886382
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.7139487540886382
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.7139487540886382
TRANSSEXUALITY	0.0188679	1.7139487540886382
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.7139487540886382
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.7139487540886382
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0188679	1.7139487540886382
ALCOHOL DEPENDENCE	0.0188679	1.7139487540886382
JUMPING FRENCHMAN OF MAINE	0.0188679	1.7139487540886382
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.7139487540886382
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.7139487540886382
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0188679	1.7139487540886382
TRICHODENTOOSSEOUS SYNDROME	0.0188679	1.7139487540886382
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.7139487540886382
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.7139487540886382
MOTION SICKNESS	0.0188679	1.7139487540886382
NEU-LAXOVA SYNDROME 2; NLS2	0.01853539	1.6837437445103594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.018399902000000003	1.671436095604336
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.018399902000000003	1.671436095604336
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.018399902000000003	1.671436095604336
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.018399902000000003	1.671436095604336
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.018399902000000003	1.671436095604336
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.018399902000000003	1.671436095604336
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018399902000000003	1.671436095604336
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.018399902000000003	1.671436095604336
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.018399902000000003	1.671436095604336
LEIGH SYNDROME; LS	0.018399902000000003	1.671436095604336
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.018399902000000003	1.671436095604336
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.018399902000000003	1.671436095604336
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.018399902000000003	1.671436095604336
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.018399902000000003	1.671436095604336
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.018399902000000003	1.671436095604336
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018399902000000003	1.671436095604336
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.018399902000000003	1.671436095604336
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.018341352000000002	1.6661174486138446
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.018237832	1.6567137537128085
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.018237832	1.6567137537128085
COHEN-GIBSON SYNDROME; COGIS	0.018200432	1.6533163600758423
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.01809771	1.6439851550176485
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.018049612	1.6396159614574666
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.01790577	1.6265494401866514
SECKEL SYNDROME 5; SCKL5	0.01790577	1.6265494401866514
LATHOSTEROLOSIS	0.01790577	1.6265494401866514
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.01755602	1.5947783593168934
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.01755602	1.5947783593168934
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.01755602	1.5947783593168934
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.01755602	1.5947783593168934
LIVER FAILURE, INFANTILE, TRANSIENT	0.01755602	1.5947783593168934
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.01755602	1.5947783593168934
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.01755602	1.5947783593168934
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.01755602	1.5947783593168934
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.01755602	1.5947783593168934
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.01755602	1.5947783593168934
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.01755602	1.5947783593168934
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.01755602	1.5947783593168934
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.01755602	1.5947783593168934
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.017437522	1.584014071851834
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.017437522	1.584014071851834
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.017437522	1.584014071851834
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.017437522	1.584014071851834
EMANUEL SYNDROME	0.017164822	1.5592421669106393
RAYNAUD-CLAES SYNDROME; MRXSRC	0.017068202	1.5504652638838032
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.017029222	1.5469243439915852
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01674373	1.5209904214192653
MECKEL SYNDROME 12; MKS12	0.01659364	1.507356335564392
DUBOWITZ SYNDROME	0.01659364	1.507356335564392
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.01659364	1.507356335564392
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.01659364	1.507356335564392
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01659364	1.507356335564392
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.01659364	1.507356335564392
MECKEL SYNDROME, TYPE 1; MKS1	0.01659364	1.507356335564392
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.01643455	1.4929046950909974
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.01643455	1.4929046950909974
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.01643455	1.4929046950909974
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.016296082	1.4803263447668413
WHITE-SUTTON SYNDROME; WHSUS	0.016296082	1.4803263447668413
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01626449	1.4774565463770275
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.01618534	1.470266607704143
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.015756072	1.4312721592615436
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0154522	1.4036686084793992
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.015366702	1.3959020212822513
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.015336682	1.3931750224324726
WARSAW BREAKAGE SYNDROME; WABS	0.015336682	1.3931750224324726
PEHO-LIKE SYNDROME; PEHOL	0.015336682	1.3931750224324726
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.015336682	1.3931750224324726
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.015336682	1.3931750224324726
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.015336682	1.3931750224324726
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.015336682	1.3931750224324726
LISSENCEPHALY 2; LIS2	0.015336682	1.3931750224324726
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.015336682	1.3931750224324726
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.015336682	1.3931750224324726
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.015336682	1.3931750224324726
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.015336682	1.3931750224324726
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.015336682	1.3931750224324726
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.015336682	1.3931750224324726
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.015336682	1.3931750224324726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.015126452	1.3740778549378359
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.015126452	1.3740778549378359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.015126452	1.3740778549378359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.014928382	1.3560852945722235
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.014928382	1.3560852945722235
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.014928382	1.3560852945722235
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.014928382	1.3560852945722235
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.014928382	1.3560852945722235
METHYLMALONIC ACIDURIA, CBLB TYPE	0.014928382	1.3560852945722235
METHYLMALONIC ACIDURIA, CBLA TYPE	0.014928382	1.3560852945722235
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.014928382	1.3560852945722235
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014928382	1.3560852945722235
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.014928382	1.3560852945722235
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.014928382	1.3560852945722235
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.014554412	1.322114083384623
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.014554412	1.322114083384623
WIEDEMANN-STEINER SYNDROME; WDSTS	0.014554412	1.322114083384623
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.014554412	1.322114083384623
HYPOTONIA-CYSTINURIA SYNDROME	0.014545532	1.3213074294943485
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0144928	1.3165172861450305
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0144928	1.3165172861450305
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.0144928	1.3165172861450305
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0144928	1.3165172861450305
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0144928	1.3165172861450305
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0144928	1.3165172861450305
MICROCEPHALY, AUTOSOMAL DOMINANT	0.0144928	1.3165172861450305
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.0144928	1.3165172861450305
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.0144928	1.3165172861450305
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0144928	1.3165172861450305
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.0144928	1.3165172861450305
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.0144928	1.3165172861450305
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.0144928	1.3165172861450305
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.0144928	1.3165172861450305
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0144928	1.3165172861450305
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.0144928	1.3165172861450305
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0144928	1.3165172861450305
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.0144928	1.3165172861450305
MICROHYDRANENCEPHALY; MHAC	0.0144928	1.3165172861450305
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0144928	1.3165172861450305
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.0144928	1.3165172861450305
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.0144928	1.3165172861450305
#256520 NEU-LAXOVA SYNDROME; NLS	0.0144928	1.3165172861450305
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.0144928	1.3165172861450305
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01437919	1.30619702167723
DESANTO-SHINAWI SYNDROME	0.014195242	1.2894872953474796
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0140845	1.2794275582847814
SUDDEN CARDIAC FAILURE, INFANTILE	0.0140845	1.2794275582847814
GLUTARIC ACIDEMIA I; GA1	0.0140845	1.2794275582847814
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.0140845	1.2794275582847814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0140845	1.2794275582847814
LACTASE DEFICIENCY, CONGENITAL	0.0140845	1.2794275582847814
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.0140845	1.2794275582847814
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.0140845	1.2794275582847814
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.0140845	1.2794275582847814
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.0140845	1.2794275582847814
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.0140845	1.2794275582847814
RIBOFLAVIN DEFICIENCY	0.0140845	1.2794275582847814
HAWKINSINURIA	0.0140845	1.2794275582847814
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0140845	1.2794275582847814
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.0140845	1.2794275582847814
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.0140845	1.2794275582847814
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.0140845	1.2794275582847814
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.013982620000000001	1.2701728400031207
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.013982620000000001	1.2701728400031207
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.013982620000000001	1.2701728400031207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.013814322	1.2548847503155767
COFFIN-SIRIS SYNDROME 1; CSS1	0.013454082000000001	1.2221607641182315
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.013454082	1.2221607641182313
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.013454082	1.2221607641182313
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.013454082	1.2221607641182313
LAMB-SHAFFER SYNDROME	0.013454082	1.2221607641182313
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.013454082	1.2221607641182313
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.013454082	1.2221607641182313
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.01331396	1.2094321654230713
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.013122232	1.1920157085453105
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.013083191999999999	1.188469338288969
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013083191999999999	1.188469338288969
SCHAAF-YANG SYNDROME; SHFYNG	0.013083191999999999	1.188469338288969
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.01297044	1.1782270140281346
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.012811349999999999	1.1637753735547398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.012811349999999999	1.1637753735547398
HYPERMANGANESEMIA WITH DYSTONIA 2	0.012686622	1.1524451566148597
FONTAINE PROGEROID SYNDROME; FPS	0.0126102	1.1455030278307892
LATERAL MENINGOCELE SYNDROME	0.0126102	1.1455030278307892
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.0126102	1.1455030278307892
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.012453572	1.131275033965261
COFFIN-SIRIS SYNDROME 6; CSS6	0.012453572	1.131275033965261
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01227835	1.1153579722578684
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.01227835	1.1153579722578684
KAPUR-TORIELLO SYNDROME	0.01223931	1.1118116020015272
MYOPATHY, DISTAL, 1; MPD1	0.011842740000000001	1.0757874203274176
TENORIO SYNDROME; TNORS	0.011842740000000001	1.0757874203274176
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.011842740000000001	1.0757874203274176
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.011842740000000001	1.0757874203274176
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.011842740000000001	1.0757874203274176
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.011794642	1.0714182267672356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011713482	1.064045700896215
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.011713482	1.064045700896215
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.011713482	1.064045700896215
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.011713482	1.064045700896215
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011713482	1.064045700896215
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.011713482	1.064045700896215
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.011713482	1.064045700896215
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.011713482	1.064045700896215
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.011713482	1.064045700896215
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.011713482	1.064045700896215
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011713482	1.064045700896215
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.011713482	1.064045700896215
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.011713482	1.064045700896215
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011713482	1.064045700896215
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.011713482	1.064045700896215
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.011713482	1.064045700896215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.011713482	1.064045700896215
AUTISM, SUSCEPTIBILITY TO, 18	0.011609689999999999	1.054617297677819
CREE MENTAL RETARDATION SYNDROME	0.011512332	1.045773355172264
NOONAN SYNDROME 3; NS3	0.011512332	1.045773355172264
ELSAHY-WATERS SYNDROME; ESWS	0.011512332	1.045773355172264
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.011512332	1.045773355172264
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.011512332	1.045773355172264
RAINE SYNDROME	0.011512332	1.045773355172264
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.011512332	1.045773355172264
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.011512332	1.045773355172264
AL KAISSI SYNDROME; ALKAS	0.011512332	1.045773355172264
JOUBERT SYNDROME 14	0.011512332	1.045773355172264
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.011512332	1.045773355172264
NOONAN SYNDROME 11; NS11	0.011512332	1.045773355172264
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.011512332	1.045773355172264
MEVALONIC ACIDURIA; MEVA	0.011512332	1.045773355172264
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.011337110000000001	1.0298562934648714
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.011332642	1.0294504230164765
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.010982351999999999	0.9976302888696075
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.010982351999999999	0.9976302888696075
SMITH-MAGENIS SYNDROME; SMS	0.010982351999999999	0.9976302888696075
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.010982351999999999	0.9976302888696075
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.010982351999999999	0.9976302888696075
HOLOPROSENCEPHALY 2; HPE2	0.010982351999999999	0.9976302888696075
LEBER OPTIC ATROPHY AND DYSTONIA	0.01095076	0.9947604904797936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.0108696	0.9873879646087729
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0108696	0.9873879646087729
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0108696	0.9873879646087729
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0108696	0.9873879646087729
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0108696	0.9873879646087729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.0108696	0.9873879646087729
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.0108696	0.9873879646087729
HYDROCEPHALUS, NORMAL-PRESSURE	0.010744872	0.9760577476688925
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.010744872	0.9760577476688925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.010744872	0.9760577476688925
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.010744872	0.9760577476688925
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010744872	0.9760577476688925
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.010744872	0.9760577476688925
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.010744872	0.9760577476688925
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.010744872	0.9760577476688925
JOUBERT SYNDROME 24	0.010744872	0.9760577476688925
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.010744872	0.9760577476688925
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.010744872	0.9760577476688925
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.010744872	0.9760577476688925
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.010744872	0.9760577476688925
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.01066845	0.9691156188848221
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.01066845	0.9691156188848221
SCARF SYNDROME	0.01066845	0.9691156188848221
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.01066845	0.9691156188848221
MEIER-GORLIN SYNDROME 3; MGORS3	0.01066845	0.9691156188848221
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.01066845	0.9691156188848221
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.01066845	0.9691156188848221
AYME-GRIPP SYNDROME; AYGRP	0.01066845	0.9691156188848221
CHROMOSOME 10Q26 DELETION SYNDROME	0.010439322	0.9483017683700948
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.010297559999999999	0.9354241930555599
RETT SYNDROME, CONGENITAL VARIANT	0.01013847	0.9209725525821654
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.01013847	0.9209725525821654
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01013847	0.9209725525821654
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.01013847	0.9209725525821654
RETT SYNDROME; RTT	0.01013847	0.9209725525821654
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.010041112	0.9121286100766103
CHROMOSOME 9P DELETION SYNDROME	0.010041112	0.9121286100766103
SHASHI-PENA SYNDROME; SHAPNS	0.010041112	0.9121286100766103
C SYNDROME	0.010041112	0.9121286100766103
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.010041112	0.9121286100766103
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.010041112	0.9121286100766103
RECOMBINANT CHROMOSOME 8 SYNDROME	0.010041112	0.9121286100766103
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00990099	0.8994000113814505
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.8994000113814505
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00990099	0.8994000113814505
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00990099	0.8994000113814505
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.8994000113814505
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.8994000113814505
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00990099	0.8994000113814505
#156550 KNIEST DYSPLASIA	0.00990099	0.8994000113814505
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.8994000113814505
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.8994000113814505
MAST SYNDROME	0.00990099	0.8994000113814505
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00990099	0.8994000113814505
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00990099	0.8994000113814505
MELNICK-NEEDLES SYNDROME	0.00990099	0.8994000113814505
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.8994000113814505
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.00990099	0.8994000113814505
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.8994000113814505
BEHR SYNDROME	0.00990099	0.8994000113814505
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00990099	0.8994000113814505
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.00990099	0.8994000113814505
DYSTONIA 23; DYT23	0.00990099	0.8994000113814505
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00990099	0.8994000113814505
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00990099	0.8994000113814505
MYOCLONIC EPILEPSY OF LAFORA	0.00990099	0.8994000113814505
NONAKA MYOPATHY	0.00990099	0.8994000113814505
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00990099	0.8994000113814505
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00990099	0.8994000113814505
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.00990099	0.8994000113814505
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00990099	0.8994000113814505
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00990099	0.8994000113814505
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00990099	0.8994000113814505
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00990099	0.8994000113814505
METACHROMATIC LEUKODYSTROPHY	0.00990099	0.8994000113814505
COCKAYNE SYNDROME A; CSA	0.00990099	0.8994000113814505
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00990099	0.8994000113814505
MOEBIUS SYNDROME; MBS	0.00990099	0.8994000113814505
ALZHEIMER DISEASE 3; AD	0.00990099	0.8994000113814505
NEMALINE MYOPATHY 6	0.00990099	0.8994000113814505
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00990099	0.8994000113814505
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00990099	0.8994000113814505
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00990099	0.8994000113814505
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00990099	0.8994000113814505
TRYPTOPHANURIA WITH DWARFISM	0.00990099	0.8994000113814505
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00990099	0.8994000113814505
KUFOR-RAKEB SYNDROME	0.00990099	0.8994000113814505
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00990099	0.8994000113814505
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00990099	0.8994000113814505
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00990099	0.8994000113814505
DYSTONIA 16; DYT16	0.00990099	0.8994000113814505
NEMALINE MYOPATHY 7; NEM7	0.00990099	0.8994000113814505
BRITTLE CORNEA SYNDROME 2; BCS2	0.00990099	0.8994000113814505
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.8994000113814505
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.00990099	0.8994000113814505
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.8994000113814505
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.8994000113814505
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00990099	0.8994000113814505
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00990099	0.8994000113814505
224550 DYSTONIA WITH RINGBINDEN	0.00990099	0.8994000113814505
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00990099	0.8994000113814505
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00990099	0.8994000113814505
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.009852892	0.8950308178212687
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.009852892	0.8950308178212687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.009852892	0.8950308178212687
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.009852892	0.8950308178212687
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009852892	0.8950308178212687
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.009852892	0.8950308178212687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.009852892	0.8950308178212687
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.009852892	0.8950308178212687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.009852892	0.8950308178212687
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.009852892	0.8950308178212687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.009852892	0.8950308178212687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009852892	0.8950308178212687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.009852892	0.8950308178212687
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.009852892	0.8950308178212687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.009852892	0.8950308178212687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.009852892	0.8950308178212687
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.009852892	0.8950308178212687
FRIAS SYNDROME	0.009411492	0.8549343057529024
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009411492	0.8549343057529024
GABRIELE-DE VRIES SYNDROME; GADEVS	0.009411492	0.8549343057529024
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.009411492	0.8549343057529024
NOONAN SYNDROME 2; NS2	0.009411492	0.8549343057529024
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.009411492	0.8549343057529024
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.009390892000000001	0.8530630140705094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.009390892000000001	0.8530630140705094
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.009390892000000001	0.8530630140705094
INFANTILE LIVER FAILURE SYNDROME 1	0.009390892000000001	0.8530630140705094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.009390892000000001	0.8530630140705094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.009390892000000001	0.8530630140705094
NAVAJO NEUROHEPATOPATHY	0.009390892000000001	0.8530630140705094
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.009390892000000001	0.8530630140705094
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.009390892000000001	0.8530630140705094
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.009390892000000001	0.8530630140705094
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.009390892000000001	0.8530630140705094
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.009390892000000001	0.8530630140705094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.009390892000000001	0.8530630140705094
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.009390892000000001	0.8530630140705094
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.009390892000000001	0.8530630140705094
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.009390892000000001	0.8530630140705094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.009390892000000001	0.8530630140705094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.009390892000000001	0.8530630140705094
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.009390892000000001	0.8530630140705094
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.009390892000000001	0.8530630140705094
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00919723	0.8354708737891684
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00919723	0.8354708737891684
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00919723	0.8354708737891684
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00919723	0.8354708737891684
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00919723	0.8354708737891684
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00919723	0.8354708737891684
NIEMANN-PICK DISEASE, TYPE A	0.009040602	0.8212428799236403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.009040602	0.8212428799236403
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.009040602	0.8212428799236403
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.009040602	0.8212428799236403
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.009040602	0.8212428799236403
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.009040602	0.8212428799236403
Xq28 (MECP2) duplication	0.009040602	0.8212428799236403
300270 ADRENOMYODYSTROPHY	0.009040602	0.8212428799236403
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.009040602	0.8212428799236403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.009040602	0.8212428799236403
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.009040602	0.8212428799236403
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00900901	0.8183730815338264
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00900901	0.8183730815338264
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00900901	0.8183730815338264
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00900901	0.8183730815338264
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00900901	0.8183730815338264
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00900901	0.8183730815338264
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.00900901	0.8183730815338264
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00900901	0.8183730815338264
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00900901	0.8183730815338264
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00900901	0.8183730815338264
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00900901	0.8183730815338264
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00900901	0.8183730815338264
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.00900901	0.8183730815338264
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00900901	0.8183730815338264
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00900901	0.8183730815338264
PERRAULT SYNDROME 5; PRLTS5	0.00900901	0.8183730815338264
#615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	0.00900901	0.8183730815338264
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00900901	0.8183730815338264
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00900901	0.8183730815338264
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00900901	0.8183730815338264
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.008968102	0.8146570232744411
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00856761	0.7782765694654603
MEIER-GORLIN SYNDROME 6; MGORS6	0.00856761	0.7782765694654603
MARTSOLF SYNDROME	0.00856761	0.7782765694654603
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00856761	0.7782765694654603
ACROCALLOSAL SYNDROME; ACLS	0.00856761	0.7782765694654603
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00854701	0.7764052777830672
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00854701	0.7764052777830672
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00854701	0.7764052777830672
PSEUDO-TORCH SYNDROME 2	0.00854701	0.7764052777830672
GLYCOGEN STORAGE DISEASE IXC	0.00854701	0.7764052777830672
MAPLE SYRUP URINE DISEASE; MSUD	0.00854701	0.7764052777830672
PHENFORMIN 4-HYDROXYLATION	0.00854701	0.7764052777830672
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00854701	0.7764052777830672
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00854701	0.7764052777830672
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00854701	0.7764052777830672
GLYCOGEN STORAGE DISEASE IB	0.00854701	0.7764052777830672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00854701	0.7764052777830672
SUCCINIC ACIDEMIA	0.00854701	0.7764052777830672
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.00854701	0.7764052777830672
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00854701	0.7764052777830672
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00854701	0.7764052777830672
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00854701	0.7764052777830672
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00854701	0.7764052777830672
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00854701	0.7764052777830672
GLYCOGEN STORAGE DISEASE IA	0.00854701	0.7764052777830672
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00854701	0.7764052777830672
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4	0.00854701	0.7764052777830672
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00854701	0.7764052777830672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00854701	0.7764052777830672
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00854701	0.7764052777830672
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00854701	0.7764052777830672
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00854701	0.7764052777830672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00854701	0.7764052777830672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.008299441999999999	0.7539163486943918
ZTTK SYNDROME; ZTTKS	0.008299441999999999	0.7539163486943918
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.008299441999999999	0.7539163486943918
OGDEN SYNDROME; OGDNS	0.008299441999999999	0.7539163486943918
PORPHYRIA VARIEGATA	0.00819672	0.7445851436361982
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00819672	0.7445851436361982
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	0.7445851436361982
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00819672	0.7445851436361982
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00819672	0.7445851436361982
MYXEDEMA	0.00819672	0.7445851436361982
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00819672	0.7445851436361982
ANAL SPHINCTER DYSPLASIA; ASDP	0.00819672	0.7445851436361982
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	0.7445851436361982
VISCERAL MYOPATHY; VSCM	0.00819672	0.7445851436361982
UROFACIAL SYNDROME	0.00819672	0.7445851436361982
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	0.7445851436361982
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	0.7445851436361982
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	0.7445851436361982
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	0.7445851436361982
UROFACIAL SYNDROME 2	0.00819672	0.7445851436361982
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.00819672	0.7445851436361982
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	0.7445851436361982
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00819672	0.7445851436361982
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00819672	0.7445851436361982
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00819672	0.7445851436361982
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00819672	0.7445851436361982
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	0.7445851436361982
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00819672	0.7445851436361982
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00819672	0.7445851436361982
GITELMAN SYNDROME	0.00819672	0.7445851436361982
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00819672	0.7445851436361982
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	0.7445851436361982
FG SYNDROME 2; FGS2	0.00819672	0.7445851436361982
HYPOPHOSPHATASIA, INFANTILE	0.00819672	0.7445851436361982
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	0.7445851436361982
ADIPOSIS DOLOROSA	0.00819672	0.7445851436361982
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.008099362	0.7357412011306432
CHROMOSOME 16Q22 DELETION SYNDROME	0.008099362	0.7357412011306432
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.008099362	0.7357412011306432
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.008099362	0.7357412011306432
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.008099362	0.7357412011306432
CHROMOSOME 15Q14 DELETION SYNDROME	0.008099362	0.7357412011306432
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.008099362	0.7357412011306432
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.008099362	0.7357412011306432
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.008099362	0.7357412011306432
PEROXISOME BIOGENESIS DISORDER 10B	0.008099362	0.7357412011306432
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.008099362	0.7357412011306432
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008099362	0.7357412011306432
FRONTOOCULAR SYNDROME	0.008099362	0.7357412011306432
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.008099362	0.7357412011306432
HADZISELIMOVIC SYNDROME	0.008099362	0.7357412011306432
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.008099362	0.7357412011306432
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.008099362	0.7357412011306432
OROFACIODIGITAL SYNDROME VI	0.008099362	0.7357412011306432
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.008099362	0.7357412011306432
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.008099362	0.7357412011306432
HARTSFIELD SYNDROME; HRTFDS	0.008099362	0.7357412011306432
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.008099362	0.7357412011306432
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.008099362	0.7357412011306432
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.008099362	0.7357412011306432
TARP SYNDROME; TARPS	0.008099362	0.7357412011306432
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008099362	0.7357412011306432
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.007940272	0.7212895606572486
CRI-DU-CHAT SYNDROME	0.00745556	0.6772586124069498
15q26 overgrowth syndrome	0.00745556	0.6772586124069498
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00745556	0.6772586124069498
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00745556	0.6772586124069498
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00745556	0.6772586124069498
#278250 WRINKLY SKIN SYNDROME; WSS	0.00745556	0.6772586124069498
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00745556	0.6772586124069498
HALLERMANN-STREIFF SYNDROME; HSS	0.00745556	0.6772586124069498
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00745556	0.6772586124069498
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00745556	0.6772586124069498
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00745556	0.6772586124069498
NOONAN SYNDROME 7; NS7	0.00745556	0.6772586124069498
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00745556	0.6772586124069498
COFFIN-SIRIS SYNDROME 10; CSS10	0.00725548	0.6590834648432011
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00725548	0.6590834648432011
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00725548	0.6590834648432011
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00725548	0.6590834648432011
#613707 LEOPARD SYNDROME 3; LPRD3	0.00725548	0.6590834648432011
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.00725548	0.6590834648432011
CEREBROOCULONASAL SYNDROME	0.00725548	0.6590834648432011
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00725548	0.6590834648432011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00725548	0.6590834648432011
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00725548	0.6590834648432011
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00725548	0.6590834648432011
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00725548	0.6590834648432011
SIMOSA CRANIOFACIAL SYNDROME	0.00725548	0.6590834648432011
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00725548	0.6590834648432011
WIDOW&#39;S PEAK SYNDROME	0.00725548	0.6590834648432011
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00725548	0.6590834648432011
SPONDYLOOCULAR SYNDROME; SOS	0.00725548	0.6590834648432011
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00725548	0.6590834648432011
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00725548	0.6590834648432011
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00725548	0.6590834648432011
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00725548	0.6590834648432011
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00725548	0.6590834648432011
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00725548	0.6590834648432011
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00725548	0.6590834648432011
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00725548	0.6590834648432011
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00725548	0.6590834648432011
OTOONYCHOPERONEAL SYNDROME	0.00725548	0.6590834648432011
BRANCHIOOCULOFACIAL SYNDROME	0.00725548	0.6590834648432011
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00725548	0.6590834648432011
DIAMOND-BLACKFAN ANEMIA 10	0.00725548	0.6590834648432011
FEINGOLD SYNDROME 1; FGLDS1	0.00725548	0.6590834648432011
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00725548	0.6590834648432011
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00725548	0.6590834648432011
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00725548	0.6590834648432011
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00725548	0.6590834648432011
PSEUDOTRISOMY 13 SYNDROME	0.00725548	0.6590834648432011
ZIMMERMANN-LABAND SYNDROME 1	0.00709639	0.6446318243698066
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00709639	0.6446318243698066
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00709639	0.6446318243698066
LARSEN-LIKE SYNDROME	0.007026352	0.6382696143284738
TEMTAMY SYNDROME; TEMTYS	0.006357692	0.5775289397484248
XIA-GIBBS SYNDROME	0.006357692	0.5775289397484248
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.006357692	0.5775289397484248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.006357692	0.5775289397484248
NOONAN SYNDROME 5; NS5	0.006357692	0.5775289397484248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.006357692	0.5775289397484248
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.006357692	0.5775289397484248
GOLDBERG-SHPRINTZEN SYNDROME	0.006357692	0.5775289397484248
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006357692	0.5775289397484248
GLASS SYNDROME	0.006357692	0.5775289397484248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006357692	0.5775289397484248
JOUBERT SYNDROME 10	0.006357692	0.5775289397484248
RITSCHER-SCHINZEL SYNDROME 1	0.006357692	0.5775289397484248
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.006357692	0.5775289397484248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.006357692	0.5775289397484248
RING CHROMOSOME 14 SYNDROME	0.006357692	0.5775289397484248
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.006198601999999999	0.5630772992750301
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.006198601999999999	0.5630772992750301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.006198601999999999	0.5630772992750301
WEAVER SYNDROME	0.006198601999999999	0.5630772992750301
Aarskog-Scott syndrome	0.006198601999999999	0.5630772992750301
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.006198601999999999	0.5630772992750301
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.006198601999999999	0.5630772992750301
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.006198601999999999	0.5630772992750301
CHROMOSOME 16p13.3 DELETION SYNDROME	0.006198601999999999	0.5630772992750301
TRISOMY 18-LIKE SYNDROME	0.006182470000000001	0.5616118780410319
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.006182470000000001	0.5616118780410319
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.006182470000000001	0.5616118780410319
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00602338	0.5471602375676373
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.00602338	0.5471602375676373
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00602338	0.5471602375676373
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00602338	0.5471602375676373
ASPARTYLGLUCOSAMINURIA; AGU	0.00602338	0.5471602375676373
GAPO SYNDROME; GAPOS	0.00602338	0.5471602375676373
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00602338	0.5471602375676373
PALLISTER-HALL SYNDROME	0.005998522	0.5449021517112814
CORNELIA DE LANGE SYNDROME 3	0.005998522	0.5449021517112814
MACDERMOT-WINTER SYNDROME	0.005998522	0.5449021517112814
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.005998522	0.5449021517112814
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.005998522	0.5449021517112814
IMMUNODEFICIENCY 49; IMD49	0.005998522	0.5449021517112814
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.005998522	0.5449021517112814
TRICHOHEPATOENTERIC SYNDROME 1	0.00551381	0.5008712034609828
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00551381	0.5008712034609828
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00551381	0.5008712034609828
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00551381	0.5008712034609828
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00551381	0.5008712034609828
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00551381	0.5008712034609828
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00551381	0.5008712034609828
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00551381	0.5008712034609828
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00551381	0.5008712034609828
NOONAN SYNDROME 8; NS8	0.00551381	0.5008712034609828
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00551381	0.5008712034609828
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00551381	0.5008712034609828
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00551381	0.5008712034609828
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00551381	0.5008712034609828
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00551381	0.5008712034609828
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00551381	0.5008712034609828
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00551381	0.5008712034609828
FRANK-TER HAAR SYNDROME; FTHS	0.00551381	0.5008712034609828
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00551381	0.5008712034609828
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00551381	0.5008712034609828
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00551381	0.5008712034609828
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00551381	0.5008712034609828
CHROMOSOME 17q12 DELETION SYNDROME	0.00535472	0.48641956298758815
NOONAN SYNDROME 4; NS4	0.00535472	0.48641956298758815
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00535472	0.48641956298758815
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00535472	0.48641956298758815
FRONTOMETAPHYSEAL DYSPLASIA	0.00535472	0.48641956298758815
CHARGE SYNDROME	0.00535472	0.48641956298758815
RUVALCABA SYNDROME	0.00535472	0.48641956298758815
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.00535472	0.48641956298758815
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.00535472	0.48641956298758815
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00535472	0.48641956298758815
MACS SYNDROME	0.00535472	0.48641956298758815
CHROMOSOME 18Q DELETION SYNDROME	0.00535472	0.48641956298758815
SOTOS SYNDROME 2	0.00535472	0.48641956298758815
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00535472	0.48641956298758815
ATKIN-FLAITZ SYNDROME	0.00535472	0.48641956298758815
CLARK-BARAITSER SYNDROME	0.00535472	0.48641956298758815
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00535472	0.48641956298758815
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00535472	0.48641956298758815
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00535472	0.48641956298758815
600736 VELOFACIOSKELETAL SYNDROME	0.00515464	0.4682444154238394
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00515464	0.4682444154238394
FLOATING-HARBOR SYNDROME	0.00515464	0.4682444154238394
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.00515464	0.4682444154238394
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.00515464	0.4682444154238394
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00515464	0.4682444154238394
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00515464	0.4682444154238394
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00515464	0.4682444154238394
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00515464	0.4682444154238394
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00515464	0.4682444154238394
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00515464	0.4682444154238394
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00515464	0.4682444154238394
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00515464	0.4682444154238394
REVESZ SYNDROME	0.004925512	0.44743056490911215
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004925512	0.44743056490911215
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004925512	0.44743056490911215
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004925512	0.44743056490911215
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.004925512	0.44743056490911215
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004925512	0.44743056490911215
#170100 PROLIDASE DEFICIENCY	0.004925512	0.44743056490911215
SALLA DISEASE	0.004925512	0.44743056490911215
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.004925512	0.44743056490911215
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004925512	0.44743056490911215
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004925512	0.44743056490911215
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.44743056490911215
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004925512	0.44743056490911215
WIEACKER-WOLFF SYNDROME	0.004886471999999999	0.44388419465277096
ALAZAMI SYNDROME; ALAZS	0.004886471999999999	0.44388419465277096
JABERI-ELAHI SYNDROME; JABELS	0.004886471999999999	0.44388419465277096
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.004886471999999999	0.44388419465277096
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.004886471999999999	0.44388419465277096
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.004886471999999999	0.44388419465277096
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.004886471999999999	0.44388419465277096
CEREBELLOFACIODENTAL SYNDROME	0.004886471999999999	0.44388419465277096
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004886471999999999	0.44388419465277096
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004886471999999999	0.44388419465277096
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.004886471999999999	0.44388419465277096
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.004886471999999999	0.44388419465277096
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004886471999999999	0.44388419465277096
DIGEORGE SYNDROME; DGS	0.004886471999999999	0.44388419465277096
CRANIOFRONTONASAL SYNDROME; CFNS	0.004256852	0.3866898903290631
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.004256852	0.3866898903290631
GABA-TRANSAMINASE DEFICIENCY	0.004256852	0.3866898903290631
CHROMOSOME 15q25 DELETION SYNDROME	0.004256852	0.3866898903290631
Muenke syndrome	0.004256852	0.3866898903290631
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.004256852	0.3866898903290631
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.004256852	0.3866898903290631
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004256852	0.3866898903290631
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.004256852	0.3866898903290631
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.004256852	0.3866898903290631
SHUKLA-VERNON SYNDROME; SHUVER	0.004256852	0.3866898903290631
THAUVIN-ROBINET-FAIVRE SYNDROME	0.004256852	0.3866898903290631
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004256852	0.3866898903290631
3MC SYNDROME 2	0.004256852	0.3866898903290631
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004256852	0.3866898903290631
NOONAN SYNDROME 9; NS9	0.004256852	0.3866898903290631
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.004256852	0.3866898903290631
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004256852	0.3866898903290631
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.004256852	0.3866898903290631
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.004256852	0.3866898903290631
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.004256852	0.3866898903290631
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.004256852	0.3866898903290631
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.004256852	0.3866898903290631
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.004256852	0.3866898903290631
GENITOPATELLAR SYNDROME; GTPTS	0.004256852	0.3866898903290631
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.004256852	0.3866898903290631
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.004256852	0.3866898903290631
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.004256852	0.3866898903290631
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004256852	0.3866898903290631
LUSCAN-LUMISH SYNDROME; LLS	0.004256852	0.3866898903290631
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.004256852	0.3866898903290631
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004256852	0.3866898903290631
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.3707728286216701
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.3707728286216701
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00408163	0.3707728286216701
ICHTHYOSIS, X-LINKED	0.00408163	0.3707728286216701
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.3707728286216701
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.3707728286216701
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.3707728286216701
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.3707728286216701
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.3707728286216701
XM SYSTEM	0.00408163	0.3707728286216701
XYLOSIDASE DEFICIENCY	0.00408163	0.3707728286216701
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.3707728286216701
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.3707728286216701
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.3707728286216701
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.3707728286216701
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00408163	0.3707728286216701
EHLERS-DANLOS SYNDROME, TYPE VI	0.00408163	0.3707728286216701
COUMARIN RESISTANCE	0.00408163	0.3707728286216701
ACETYLATION, SLOW	0.00408163	0.3707728286216701
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.3707728286216701
MYOPATHY, SPHEROID BODY	0.00408163	0.3707728286216701
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00408163	0.3707728286216701
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.3707728286216701
OSTEOGENIC SARCOMA	0.00408163	0.3707728286216701
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.3707728286216701
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.3707728286216701
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.3707728286216701
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.3707728286216701
HYPERLEUCINE-ISOLEUCINEMIA	0.00408163	0.3707728286216701
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.3707728286216701
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.3707728286216701
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.3707728286216701
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00408163	0.3707728286216701
MACROCYTOSIS, FAMILIAL	0.00408163	0.3707728286216701
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.3707728286216701
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.3707728286216701
DERMATITIS, ATOPIC	0.00408163	0.3707728286216701
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.3707728286216701
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.3707728286216701
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.3707728286216701
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.3707728286216701
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.3707728286216701
CEPHALIN LIPIDOSIS	0.00408163	0.3707728286216701
CITRULLINE TRANSPORT DEFECT	0.00408163	0.3707728286216701
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.3707728286216701
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.3707728286216701
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.3707728286216701
HEINZ BODY ANEMIAS	0.00408163	0.3707728286216701
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.3707728286216701
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00408163	0.3707728286216701
SCHIZOPHRENIA 4	0.00408163	0.3707728286216701
PERRY SYNDROME	0.00408163	0.3707728286216701
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.3707728286216701
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.3707728286216701
GLOMUVENOUS MALFORMATIONS	0.00408163	0.3707728286216701
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.3707728286216701
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00408163	0.3707728286216701
XANTHINURIA, TYPE I	0.00408163	0.3707728286216701
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.3707728286216701
PARAOXONASE 1	0.00408163	0.3707728286216701
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.3707728286216701
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00408163	0.3707728286216701
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.3707728286216701
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00408163	0.3707728286216701
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.3707728286216701
LIPASE DEFICIENCY, COMBINED	0.00408163	0.3707728286216701
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.3707728286216701
ALKAPTONURIA	0.00408163	0.3707728286216701
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.3707728286216701
PENDRED SYNDROME	0.00408163	0.3707728286216701
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.3707728286216701
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.3707728286216701
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.3707728286216701
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00408163	0.3707728286216701
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.3707728286216701
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.3707728286216701
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.3707728286216701
DELETED IN AZOOSPERMIA	0.00408163	0.3707728286216701
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.3707728286216701
AREDYLD	0.00408163	0.3707728286216701
MYELOPEROXIDASE DEFICIENCY	0.00408163	0.3707728286216701
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.3707728286216701
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.3707728286216701
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.3707728286216701
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.3707728286216701
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.3707728286216701
ONCOCYTOMA	0.00408163	0.3707728286216701
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.3707728286216701
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.3707728286216701
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.3707728286216701
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.3707728286216701
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.3707728286216701
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.3707728286216701
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.3707728286216701
GLUTATHIONE REDUCTASE	0.00408163	0.3707728286216701
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.3707728286216701
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.3707728286216701
PYGMY	0.00408163	0.3707728286216701
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.3707728286216701
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.3707728286216701
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.3707728286216701
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.3707728286216701
LYMPHOKINE DEFICIENCY	0.00408163	0.3707728286216701
CALVARIAL HYPEROSTOSIS	0.00408163	0.3707728286216701
T-SUBSTANCE ANOMALY	0.00408163	0.3707728286216701
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00408163	0.3707728286216701
NEPHROSIALIDOSIS	0.00408163	0.3707728286216701
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.3707728286216701
ICHTHYOSIS AND MALE HYPOGONADISM	0.00408163	0.3707728286216701
BEETURIA	0.00408163	0.3707728286216701
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.3707728286216701
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.3707728286216701
FINGERPRINT BODY MYOPATHY	0.00408163	0.3707728286216701
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.3707728286216701
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.3707728286216701
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.3707728286216701
BLOOD GROUP, DUFFY SYSTEM; FY	0.00408163	0.3707728286216701
PREMATURE OVARIAN FAILURE 1	0.00408163	0.3707728286216701
ETHANOLAMINOSIS	0.00408163	0.3707728286216701
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.3707728286216701
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.3707728286216701
OVARIAN CANCER	0.00408163	0.3707728286216701
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.3707728286216701
EPILEPSY-TELANGIECTASIA	0.00408163	0.3707728286216701
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.3707728286216701
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.3707728286216701
PITUITARY DWARFISM IV	0.00408163	0.3707728286216701
PACMAN DYSPLASIA	0.00408163	0.3707728286216701
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00408163	0.3707728286216701
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.3707728286216701
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.00408163	0.3707728286216701
APOLIPOPROTEIN(A)	0.00408163	0.3707728286216701
GLUTATHIONURIA	0.00408163	0.3707728286216701
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.3707728286216701
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.3707728286216701
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.3707728286216701
DERMATOLEUKODYSTROPHY	0.00408163	0.3707728286216701
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.3707728286216701
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.3707728286216701
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00408163	0.3707728286216701
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.3707728286216701
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.3707728286216701
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.3707728286216701
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.3707728286216701
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.3707728286216701
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.3707728286216701
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.00408163	0.3707728286216701
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.3707728286216701
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.3707728286216701
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.3707728286216701
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.3707728286216701
ZINC, ELEVATED PLASMA	0.00408163	0.3707728286216701
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.3707728286216701
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.3707728286216701
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.3707728286216701
CARBOXYLESTERASE 1	0.00408163	0.3707728286216701
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.3707728286216701
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.3707728286216701
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.3707728286216701
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.3707728286216701
PROGESTERONE RESISTANCE	0.00408163	0.3707728286216701
HOOFT DISEASE	0.00408163	0.3707728286216701
FLOOD FACTOR DEFICIENCY	0.00408163	0.3707728286216701
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.3707728286216701
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.3707728286216701
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.3707728286216701
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.3707728286216701
ALAND ISLAND EYE DISEASE	0.00408163	0.3707728286216701
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.3707728286216701
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.3707728286216701
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.3707728286216701
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.3707728286216701
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.3707728286216701
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.3707728286216701
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00408163	0.3707728286216701
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.3707728286216701
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.3707728286216701
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.3707728286216701
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.3707728286216701
LARON SYNDROME	0.00408163	0.3707728286216701
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.3707728286216701
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.3707728286216701
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.3707728286216701
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.3707728286216701
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00408163	0.3707728286216701
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.3707728286216701
GONADOBLASTOMA	0.00408163	0.3707728286216701
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.3707728286216701
SPINAL ARACHNOIDITIS	0.00408163	0.3707728286216701
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.3707728286216701
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.3707728286216701
HYPERPROGLUCAGONEMIA	0.00408163	0.3707728286216701
HYPOASCORBEMIA	0.00408163	0.3707728286216701
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.3707728286216701
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.3707728286216701
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.3707728286216701
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00408163	0.3707728286216701
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.3707728286216701
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00404259	0.3672264583653289
MARDEN-WALKER SYNDROME	0.00404259	0.3672264583653289
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00404259	0.3672264583653289
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00404259	0.3672264583653289
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00404259	0.3672264583653289
STUVE-WIEDEMANN SYNDROME	0.00404259	0.3672264583653289
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00404259	0.3672264583653289
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00404259	0.3672264583653289
MARSHALL-SMITH SYNDROME; MRSHSS	0.00404259	0.3672264583653289
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.00404259	0.3672264583653289
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00404259	0.3672264583653289
FOCAL DERMAL HYPOPLASIA; FDH	0.00404259	0.3672264583653289
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00341297	0.310032154041621
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00341297	0.310032154041621
MAXILLOFACIAL DYSOSTOSIS	0.00341297	0.310032154041621
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00341297	0.310032154041621
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00341297	0.310032154041621
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00341297	0.310032154041621
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00341297	0.310032154041621
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00341297	0.310032154041621
HYPERTELORISM, TEEBI TYPE; TBHS	0.00341297	0.310032154041621
2p15-16.1 microdeletion syndrome	0.00341297	0.310032154041621
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00341297	0.310032154041621
COHEN SYNDROME	0.00341297	0.310032154041621
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00341297	0.310032154041621
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00341297	0.310032154041621
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00341297	0.310032154041621
LOEYS-DIETZ SYNDROME 5	0.00341297	0.310032154041621
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00341297	0.310032154041621
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00341297	0.310032154041621
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00341297	0.310032154041621
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00341297	0.310032154041621
MEESTER-LOEYS SYNDROME; MRLS	0.00341297	0.310032154041621
Cat-Eye Syndrome (Type I)	0.00341297	0.310032154041621
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00341297	0.310032154041621
NOONAN SYNDROME 10; NS10	0.00341297	0.310032154041621
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00341297	0.310032154041621
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00341297	0.310032154041621
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00341297	0.310032154041621
TREACHER COLLINS SYNDROME 2; TCS2	0.00341297	0.310032154041621
TREACHER COLLINS SYNDROME 3; TCS3	0.00341297	0.310032154041621
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00341297	0.310032154041621
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00341297	0.310032154041621
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00341297	0.310032154041621
POTOCKI-SHAFFER SYNDROME	0.00341297	0.310032154041621
ACROCRANIOFACIAL DYSOSTOSIS	0.00341297	0.310032154041621
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00341297	0.310032154041621
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00341297	0.310032154041621
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00341297	0.310032154041621
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00341297	0.310032154041621
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00341297	0.310032154041621
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00341297	0.310032154041621
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00341297	0.310032154041621
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00341297	0.310032154041621
PROTEUS SYNDROME	0.00341297	0.310032154041621
MARFAN SYNDROME; MFS	0.00341297	0.310032154041621
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00341297	0.310032154041621
PRIMROSE SYNDROME; PRIMS	0.00341297	0.310032154041621
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00341297	0.310032154041621
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00341297	0.310032154041621
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00341297	0.310032154041621
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00341297	0.310032154041621
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00341297	0.310032154041621
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00341297	0.310032154041621
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00341297	0.310032154041621
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00341297	0.310032154041621
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00341297	0.310032154041621
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00341297	0.310032154041621
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00341297	0.310032154041621
MESOMELIA-SYNOSTOSES SYNDROME	0.00341297	0.310032154041621
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00341297	0.310032154041621
311450 PALLISTER W SYNDROME;;W SYNDROME	0.00341297	0.310032154041621
CHROMOSOME 16p13.2 DELETION SYNDROME	0.0029447220000000003	0.26749678570680385
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0029447220000000003	0.26749678570680385
DIAMOND-BLACKFAN ANEMIA 5	0.0029447220000000003	0.26749678570680385
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.0029447220000000003	0.26749678570680385
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0029447220000000003	0.26749678570680385
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0029447220000000003	0.26749678570680385
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0029447220000000003	0.26749678570680385
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0029447220000000003	0.26749678570680385
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0029447220000000003	0.26749678570680385
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0029447220000000003	0.26749678570680385
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0029447220000000003	0.26749678570680385
CATEL-MANZKE SYNDROME; CATMANS	0.0029447220000000003	0.26749678570680385
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0029447220000000003	0.26749678570680385
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0029447220000000003	0.26749678570680385
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0029447220000000003	0.26749678570680385
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0029447220000000003	0.26749678570680385
ADAMS-OLIVER SYNDROME 2; AOS2	0.0029447220000000003	0.26749678570680385
JOUBERT SYNDROME 1	0.0029447220000000003	0.26749678570680385
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0029447220000000003	0.26749678570680385
JOUBERT SYNDROME 2	0.0029447220000000003	0.26749678570680385
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0029447220000000003	0.26749678570680385
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0029447220000000003	0.26749678570680385
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0029447220000000003	0.26749678570680385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0029447220000000003	0.26749678570680385
DIAPHANOSPONDYLODYSOSTOSIS	0.0029447220000000003	0.26749678570680385
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0029447220000000003	0.26749678570680385
CHAR SYNDROME	0.0029447220000000003	0.26749678570680385
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0029447220000000003	0.26749678570680385
FORSYTHE-WAKELING SYNDROME; FWS	0.0029447220000000003	0.26749678570680385
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0029447220000000003	0.26749678570680385
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0029447220000000003	0.26749678570680385
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0029447220000000003	0.26749678570680385
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0029447220000000003	0.26749678570680385
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.0029447220000000003	0.26749678570680385
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0029447220000000003	0.26749678570680385
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0029447220000000003	0.26749678570680385
JOUBERT SYNDROME 35; JBTS35	0.0029447220000000003	0.26749678570680385
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0029447220000000003	0.26749678570680385
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0029447220000000003	0.26749678570680385
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0029447220000000003	0.26749678570680385
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0029447220000000003	0.26749678570680385
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0029447220000000003	0.26749678570680385
MEND SYNDROME; MEND	0.0029447220000000003	0.26749678570680385
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0029447220000000003	0.26749678570680385
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0029447220000000003	0.26749678570680385
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0029447220000000003	0.26749678570680385
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0029447220000000003	0.26749678570680385
AL-RAQAD SYNDROME; ARS	0.0029447220000000003	0.26749678570680385
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0029447220000000003	0.26749678570680385
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0027856319999999997	0.2530451452334092
BAKER-GORDON SYNDROME; BAGOS	0.0027856319999999997	0.2530451452334092
COFFIN-SIRIS SYNDROME 3; CSS3	0.0027856319999999997	0.2530451452334092
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0027856319999999997	0.2530451452334092
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0027856319999999997	0.2530451452334092
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.0027856319999999997	0.2530451452334092
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0027856319999999997	0.2530451452334092
Congenital disorder of glycosylation, type IIh	0.0027856319999999997	0.2530451452334092
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.0027856319999999997	0.2530451452334092
KLEEFSTRA SYNDROME 2; KLEFS2	0.0027856319999999997	0.2530451452334092
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0027856319999999997	0.2530451452334092
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.0027856319999999997	0.2530451452334092
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0027856319999999997	0.2530451452334092
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0027856319999999997	0.2530451452334092
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.0027856319999999997	0.2530451452334092
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.0027856319999999997	0.2530451452334092
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.0027856319999999997	0.2530451452334092
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0027856319999999997	0.2530451452334092
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0027856319999999997	0.2530451452334092
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0027856319999999997	0.2530451452334092
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0027856319999999997	0.2530451452334092
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.0027856319999999997	0.2530451452334092
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.0027856319999999997	0.2530451452334092
MEIER-GORLIN SYNDROME 7	0.0027856319999999997	0.2530451452334092
ALSTROM SYNDROME; ALMS	0.0027856319999999997	0.2530451452334092
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027856319999999997	0.2530451452334092
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0027856319999999997	0.2530451452334092
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.0027856319999999997	0.2530451452334092
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.0027856319999999997	0.2530451452334092
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0027856319999999997	0.2530451452334092
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0027856319999999997	0.2530451452334092
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027856319999999997	0.2530451452334092
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.0027856319999999997	0.2530451452334092
COFFIN-SIRIS SYNDROME 4; CSS4	0.0027856319999999997	0.2530451452334092
HAREL-YOON SYNDROME; HAYOS	0.0027856319999999997	0.2530451452334092
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0027856319999999997	0.2530451452334092
JOUBERT SYNDROME 7	0.0027856319999999997	0.2530451452334092
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.0027856319999999997	0.2530451452334092
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0027856319999999997	0.2530451452334092
PETTIGREW SYNDROME	0.0027856319999999997	0.2530451452334092
BETA-UREIDOPROPIONASE DEFICIENCY	0.0027856319999999997	0.2530451452334092
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0027856319999999997	0.2530451452334092
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.0027856319999999997	0.2530451452334092
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0027856319999999997	0.2530451452334092
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0027856319999999997	0.2530451452334092
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.0027856319999999997	0.2530451452334092
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.0027856319999999997	0.2530451452334092
MARINESCO-SJOGREN SYNDROME; MSS	0.0027856319999999997	0.2530451452334092
IMMUNODEFICIENCY 23; IMD23	0.0027856319999999997	0.2530451452334092
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0027856319999999997	0.2530451452334092
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0027856319999999997	0.2530451452334092
STEEL SYNDROME; STLS	0.0027856319999999997	0.2530451452334092
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.0027856319999999997	0.2530451452334092
Pontine tegmental cap dysplasia	0.0027856319999999997	0.2530451452334092
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0027856319999999997	0.2530451452334092
LYMPHEDEMA, HEREDITARY, III	0.0027856319999999997	0.2530451452334092
POPOV-CHANG SYNDROME; POPCHAS	0.0027856319999999997	0.2530451452334092
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.0027856319999999997	0.2530451452334092
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0027856319999999997	0.2530451452334092
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.0027856319999999997	0.2530451452334092
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0027856319999999997	0.2530451452334092
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0027856319999999997	0.2530451452334092
CRANIOSYNOSTOSIS 6; CRS6	0.0027856319999999997	0.2530451452334092
MIRAGE SYNDROME; MIRAGE	0.0027856319999999997	0.2530451452334092
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0027856319999999997	0.2530451452334092
CODAS SYNDROME	0.0027856319999999997	0.2530451452334092
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.0027856319999999997	0.2530451452334092
PRADER-WILLI SYNDROME; PWS	0.0027856319999999997	0.2530451452334092
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.0027856319999999997	0.2530451452334092
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.0027856319999999997	0.2530451452334092
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.0027856319999999997	0.2530451452334092
JOUBERT SYNDROME 3; JBTS3	0.00210084	0.19083904941936172
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00210084	0.19083904941936172
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00210084	0.19083904941936172
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00210084	0.19083904941936172
OROFACIODIGITAL SYNDROME IV; OFD4	0.00210084	0.19083904941936172
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00210084	0.19083904941936172
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00210084	0.19083904941936172
FIBROCHONDROGENESIS 1; FBCG1	0.00210084	0.19083904941936172
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00210084	0.19083904941936172
VERVERI-BRADY SYNDROME; VERBRAS	0.00210084	0.19083904941936172
SIFRIM-HITZ-WEISS SYNDROME	0.00210084	0.19083904941936172
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00210084	0.19083904941936172
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.00210084	0.19083904941936172
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00210084	0.19083904941936172
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00210084	0.19083904941936172
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.00210084	0.19083904941936172
GLUTAMINE DEFICIENCY, CONGENITAL	0.00210084	0.19083904941936172
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00210084	0.19083904941936172
#154780 MARSHALL SYNDROME; MRSHS	0.00210084	0.19083904941936172
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00210084	0.19083904941936172
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00210084	0.19083904941936172
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00210084	0.19083904941936172
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00210084	0.19083904941936172
FRYNS SYNDROME; FRNS	0.00210084	0.19083904941936172
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00210084	0.19083904941936172
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00210084	0.19083904941936172
HAMAMY SYNDROME; HMMS	0.00210084	0.19083904941936172
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00210084	0.19083904941936172
OROFACIODIGITAL SYNDROME III	0.00210084	0.19083904941936172
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00210084	0.19083904941936172
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00210084	0.19083904941936172
Myhre syndrome	0.00210084	0.19083904941936172
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00210084	0.19083904941936172
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.00210084	0.19083904941936172
MICROPHTHALMIA, SYNDROMIC 1	0.00210084	0.19083904941936172
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00210084	0.19083904941936172
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00210084	0.19083904941936172
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00210084	0.19083904941936172
STROMME SYNDROME; STROMS	0.00210084	0.19083904941936172
SECKEL SYNDROME 4	0.00210084	0.19083904941936172
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00210084	0.19083904941936172
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00210084	0.19083904941936172
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00210084	0.19083904941936172
KEIPERT SYNDROME; KPTS	0.00210084	0.19083904941936172
TEEBI-SHALTOUT SYNDROME; TBSH	0.00210084	0.19083904941936172
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00210084	0.19083904941936172
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00210084	0.19083904941936172
TETRAAMELIA SYNDROME 2; TETAMS2	0.00210084	0.19083904941936172
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00210084	0.19083904941936172
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00210084	0.19083904941936172
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00210084	0.19083904941936172
KYPHOMELIC DYSPLASIA	0.00210084	0.19083904941936172
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00210084	0.19083904941936172
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00210084	0.19083904941936172
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00210084	0.19083904941936172
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.00210084	0.19083904941936172
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00210084	0.19083904941936172
LISSENCEPHALY, X-LINKED, 2	0.00210084	0.19083904941936172
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00210084	0.19083904941936172
GENITOPALATOCARDIAC SYNDROME	0.00210084	0.19083904941936172
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.00210084	0.19083904941936172
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00210084	0.19083904941936172
HYDROLETHALUS SYNDROME 1	0.00210084	0.19083904941936172
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00210084	0.19083904941936172
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00210084	0.19083904941936172
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00210084	0.19083904941936172
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00210084	0.19083904941936172
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00210084	0.19083904941936172
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00210084	0.19083904941936172
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00210084	0.19083904941936172
MEIER-GORLIN SYNDROME 8; MGORS8	0.00210084	0.19083904941936172
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00210084	0.19083904941936172
TRANSALDOLASE DEFICIENCY	0.00210084	0.19083904941936172
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00210084	0.19083904941936172
FRONTONASAL DYSPLASIA 1; FND1	0.00210084	0.19083904941936172
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.00210084	0.19083904941936172
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00210084	0.19083904941936172
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00210084	0.19083904941936172
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00210084	0.19083904941936172
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.00210084	0.19083904941936172
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00210084	0.19083904941936172
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00210084	0.19083904941936172
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00210084	0.19083904941936172
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00210084	0.19083904941936172
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00210084	0.19083904941936172
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00210084	0.19083904941936172
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00210084	0.19083904941936172
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00210084	0.19083904941936172
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00210084	0.19083904941936172
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00210084	0.19083904941936172
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00210084	0.19083904941936172
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.00210084	0.19083904941936172
OTOFACIOCERVICAL SYNDROME 2	0.00210084	0.19083904941936172
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00210084	0.19083904941936172
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00210084	0.19083904941936172
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00210084	0.19083904941936172
BARBER-SAY SYNDROME; BBRSAY	0.00210084	0.19083904941936172
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00210084	0.19083904941936172
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00210084	0.19083904941936172
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00210084	0.19083904941936172
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00210084	0.19083904941936172
MEIER-GORLIN SYNDROME 1; MGORS1	0.00210084	0.19083904941936172
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00210084	0.19083904941936172
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00210084	0.19083904941936172
CAMPOMELIC DYSPLASIA	0.00210084	0.19083904941936172
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00210084	0.19083904941936172
JACOBSEN SYNDROME	0.00210084	0.19083904941936172
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00210084	0.19083904941936172
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00210084	0.19083904941936172
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.00210084	0.19083904941936172
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00210084	0.19083904941936172
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00210084	0.19083904941936172
OROFACIAL CLEFT 15	0.00210084	0.19083904941936172
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00210084	0.19083904941936172
BARTSOCAS-PAPAS SYNDROME; BPS	0.00210084	0.19083904941936172
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00210084	0.19083904941936172
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00194175	0.17638740894596713
ODONTOCHONDRODYSPLASIA; ODCD	0.00194175	0.17638740894596713
OPSISMODYSPLASIA; OPSMD	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00194175	0.17638740894596713
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00194175	0.17638740894596713
THORACOLARYNGOPELVIC DYSPLASIA	0.00194175	0.17638740894596713
LERI-WEILL DYSCHONDROSTEOSIS	0.00194175	0.17638740894596713
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00194175	0.17638740894596713
BRITTLE CORNEA SYNDROME	0.00194175	0.17638740894596713
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.00194175	0.17638740894596713
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00194175	0.17638740894596713
CLEIDOCRANIAL DYSPLASIA; CCD	0.00194175	0.17638740894596713
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00194175	0.17638740894596713
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00194175	0.17638740894596713
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00194175	0.17638740894596713
STICKLER SYNDROME, TYPE I	0.00194175	0.17638740894596713
#307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2;;CHROMOSOME Xq27.1 INTERCHROMOSOMAL INSERTION SYNDROME;;CGH;;HCG	0.00194175	0.17638740894596713
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00194175	0.17638740894596713
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00194175	0.17638740894596713
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.00194175	0.17638740894596713
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00194175	0.17638740894596713
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.00194175	0.17638740894596713
FRAGILE X MENTAL RETARDATION SYNDROME	0.00194175	0.17638740894596713
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00194175	0.17638740894596713
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00194175	0.17638740894596713
MUCOLIPIDOSIS III GAMMA	0.00194175	0.17638740894596713
MENTAL RETARDATION, X-LINKED 82	0.00194175	0.17638740894596713
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00194175	0.17638740894596713
PYCNODYSOSTOSIS	0.00194175	0.17638740894596713
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00194175	0.17638740894596713
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00194175	0.17638740894596713
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00194175	0.17638740894596713
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00194175	0.17638740894596713
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00194175	0.17638740894596713
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.00194175	0.17638740894596713
MENTAL RETARDATION, X-LINKED 102	0.00194175	0.17638740894596713
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00194175	0.17638740894596713
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00194175	0.17638740894596713
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00194175	0.17638740894596713
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00194175	0.17638740894596713
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00194175	0.17638740894596713
AICARDI SYNDROME; AIC	0.00194175	0.17638740894596713
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00194175	0.17638740894596713
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00194175	0.17638740894596713
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00194175	0.17638740894596713
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00194175	0.17638740894596713
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00194175	0.17638740894596713
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.00194175	0.17638740894596713
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00194175	0.17638740894596713
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00194175	0.17638740894596713
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00194175	0.17638740894596713
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00194175	0.17638740894596713
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.00194175	0.17638740894596713
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.00194175	0.17638740894596713
TOWNES-BROCKS SYNDROME 2; TBS2	0.00194175	0.17638740894596713
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00194175	0.17638740894596713
#614434 CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	0.00194175	0.17638740894596713
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00194175	0.17638740894596713
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.00194175	0.17638740894596713
PSEUDOACHONDROPLASIA	0.00194175	0.17638740894596713
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00194175	0.17638740894596713
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00194175	0.17638740894596713
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00194175	0.17638740894596713
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.00194175	0.17638740894596713
#150250 LARSEN SYNDROME; LRS	0.00194175	0.17638740894596713
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00194175	0.17638740894596713
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00194175	0.17638740894596713
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00194175	0.17638740894596713
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00194175	0.17638740894596713
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00194175	0.17638740894596713
DESBUQUOIS DYSPLASIA 1	0.00194175	0.17638740894596713
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.00194175	0.17638740894596713
PYLE DISEASE; PYL	0.00194175	0.17638740894596713
MARFANOID HYPERMOBILITY SYNDROME	0.00194175	0.17638740894596713
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00194175	0.17638740894596713
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00194175	0.17638740894596713
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00194175	0.17638740894596713
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.00194175	0.17638740894596713
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00194175	0.17638740894596713
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00194175	0.17638740894596713
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00194175	0.17638740894596713
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00194175	0.17638740894596713
FACIOCARDIORENAL SYNDROME	0.00194175	0.17638740894596713
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.00194175	0.17638740894596713
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00194175	0.17638740894596713
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00194175	0.17638740894596713
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00194175	0.17638740894596713
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00194175	0.17638740894596713
HURLER-SCHEIE SYNDROME	0.00194175	0.17638740894596713
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00194175	0.17638740894596713
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00194175	0.17638740894596713
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00194175	0.17638740894596713
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00194175	0.17638740894596713
#615731 NEMALINE MYOPATHY 9; NEM9	0.00194175	0.17638740894596713
NEMALINE MYOPATHY 1; NEM1	0.00194175	0.17638740894596713
DUANE-RADIAL RAY SYNDROME; DRRS	0.00194175	0.17638740894596713
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00194175	0.17638740894596713
SPONDYLOCOSTAL DYSOSTOSIS 5	0.00194175	0.17638740894596713
HUNTER-MACDONALD SYNDROME	0.00194175	0.17638740894596713
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00194175	0.17638740894596713
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00194175	0.17638740894596713
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.00194175	0.17638740894596713
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00194175	0.17638740894596713
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00194175	0.17638740894596713
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00194175	0.17638740894596713
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.00194175	0.17638740894596713
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00194175	0.17638740894596713
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.00194175	0.17638740894596713
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00194175	0.17638740894596713
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00194175	0.17638740894596713
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00194175	0.17638740894596713
SALIH MYOPATHY; SALMY	0.00194175	0.17638740894596713
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00194175	0.17638740894596713
SHPRINTZEN OMPHALOCELE SYNDROME	0.00194175	0.17638740894596713
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00194175	0.17638740894596713
OSTEOGENESIS IMPERFECTA, TYPE X	0.00194175	0.17638740894596713
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00194175	0.17638740894596713
HEMIHYPERPLASIA, ISOLATED	0.00194175	0.17638740894596713
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00194175	0.17638740894596713
Osteogenesis imperfecta, type IX	0.00194175	0.17638740894596713
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.00194175	0.17638740894596713
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00194175	0.17638740894596713
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00194175	0.17638740894596713
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00194175	0.17638740894596713
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.00194175	0.17638740894596713
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00194175	0.17638740894596713
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00194175	0.17638740894596713
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00194175	0.17638740894596713
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.00194175	0.17638740894596713
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.00194175	0.17638740894596713
BASAL CELL NEVUS SYNDROME	0.00194175	0.17638740894596713
CHIARI MALFORMATION TYPE I	0.00194175	0.17638740894596713
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00194175	0.17638740894596713
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00194175	0.17638740894596713
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00194175	0.17638740894596713
MYOCLONIC-ATONIC EPILEPSY	0.00194175	0.17638740894596713
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00194175	0.17638740894596713
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00194175	0.17638740894596713
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00194175	0.17638740894596713
RAMON SYNDROME	0.00194175	0.17638740894596713
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.00194175	0.17638740894596713
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.00194175	0.17638740894596713
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00194175	0.17638740894596713
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00194175	0.17638740894596713
NEUROFIBROMATOSIS, TYPE I	0.00194175	0.17638740894596713
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00194175	0.17638740894596713
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.00194175	0.17638740894596713
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00194175	0.17638740894596713
OROFACIODIGITAL SYNDROME V; OFD5	0.00194175	0.17638740894596713
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00194175	0.17638740894596713
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00194175	0.17638740894596713
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00194175	0.17638740894596713
LOEYS-DIETZ SYNDROME 3; LDS3	0.00194175	0.17638740894596713
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00194175	0.17638740894596713
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00194175	0.17638740894596713
ALLAN-HERNDON-DUDLEY SYNDROME	0.00194175	0.17638740894596713
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00194175	0.17638740894596713
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.00194175	0.17638740894596713
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.00194175	0.17638740894596713
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00194175	0.17638740894596713
Ullrich congenital muscular dystrophy 1	0.00194175	0.17638740894596713
CAMURATI-ENGELMANN DISEASE	0.00194175	0.17638740894596713
METATROPIC DYSPLASIA	0.00194175	0.17638740894596713
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00194175	0.17638740894596713
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00194175	0.17638740894596713
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.00194175	0.17638740894596713
#259450 BRUCK SYNDROME 1; BRKS1	0.00194175	0.17638740894596713
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00194175	0.17638740894596713
TIBIAL TORSION, BILATERAL MEDIAL	0.00194175	0.17638740894596713
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00194175	0.17638740894596713
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00194175	0.17638740894596713
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00194175	0.17638740894596713
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00194175	0.17638740894596713
NAIL-PATELLA SYNDROME	0.00194175	0.17638740894596713
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.00194175	0.17638740894596713
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00194175	0.17638740894596713
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00194175	0.17638740894596713
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00194175	0.17638740894596713
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.00194175	0.17638740894596713
CZECH DYSPLASIA, METATARSAL TYPE	0.00194175	0.17638740894596713
231970 GLUTEAL MUSCLES, ABSENCE OF	0.00194175	0.17638740894596713
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.00194175	0.17638740894596713
SPRENGEL DEFORMITY	0.00194175	0.17638740894596713
IVIC SYNDROME	0.00194175	0.17638740894596713
SYRINGOMYELIA, ISOLATED	0.00194175	0.17638740894596713
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00194175	0.17638740894596713
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00194175	0.17638740894596713
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.00194175	0.17638740894596713
MYOPATHY, SCAPULOHUMEROPERONEAL	0.00194175	0.17638740894596713
#168400 PARASTREMMATIC DWARFISM	0.00194175	0.17638740894596713
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00194175	0.17638740894596713
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.00194175	0.17638740894596713
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00194175	0.17638740894596713
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00194175	0.17638740894596713
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00194175	0.17638740894596713
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00194175	0.17638740894596713
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00194175	0.17638740894596713
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00194175	0.17638740894596713
#609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	0.00194175	0.17638740894596713
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00194175	0.17638740894596713
SPONDYLOCAMPTODACTYLY	0.00194175	0.17638740894596713
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00194175	0.17638740894596713
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00194175	0.17638740894596713
MUCOLIPIDOSIS III ALPHA/BETA	0.00194175	0.17638740894596713
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00194175	0.17638740894596713
COFFIN-SIRIS SYNDROME 8; CSS8	0.00194175	0.17638740894596713
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00194175	0.17638740894596713
XFE PROGEROID SYNDROME; XFEPS	0.00194175	0.17638740894596713
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00194175	0.17638740894596713
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00194175	0.17638740894596713
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00194175	0.17638740894596713
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00194175	0.17638740894596713
POSTERIOR COLUMN ATAXIA	0.00194175	0.17638740894596713
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00194175	0.17638740894596713
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.00194175	0.17638740894596713
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00194175	0.17638740894596713
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.00194175	0.17638740894596713
PSEUDODIASTROPHIC DYSPLASIA	0.00194175	0.17638740894596713
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000843882	0.07665773628744207
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.07665773628744207
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.07665773628744207
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.07665773628744207
Cerebral creatine deficiency syndrome 2	0.000843882	0.07665773628744207
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.07665773628744207
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.07665773628744207
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000843882	0.07665773628744207
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.07665773628744207
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.07665773628744207
XQ25 DUPLICATION SYNDROME	0.000843882	0.07665773628744207
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.07665773628744207
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.07665773628744207
CURRY-JONES SYNDROME	0.000843882	0.07665773628744207
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000843882	0.07665773628744207
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.07665773628744207
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.07665773628744207
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.07665773628744207
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000843882	0.07665773628744207
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000843882	0.07665773628744207
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.07665773628744207
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.07665773628744207
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000843882	0.07665773628744207
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000843882	0.07665773628744207
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000843882	0.07665773628744207
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000843882	0.07665773628744207
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.07665773628744207
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.07665773628744207
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.07665773628744207
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.000843882	0.07665773628744207
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.07665773628744207
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.07665773628744207
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.07665773628744207
WAARDENBURG-SHAH SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000843882	0.07665773628744207
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.07665773628744207
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.07665773628744207
SECKEL SYNDROME 8; SCKL8	0.000843882	0.07665773628744207
ROIFMAN-CHITAYAT SYNDROME	0.000843882	0.07665773628744207
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.07665773628744207
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.07665773628744207
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000843882	0.07665773628744207
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.07665773628744207
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.07665773628744207
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000843882	0.07665773628744207
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.07665773628744207
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.07665773628744207
MECKEL SYNDROME 13; MKS13	0.000843882	0.07665773628744207
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.07665773628744207
ARIMA SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.07665773628744207
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.07665773628744207
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.07665773628744207
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.07665773628744207
JOUBERT SYNDROME 21	0.000843882	0.07665773628744207
SECKEL SYNDROME 9; SCKL9	0.000843882	0.07665773628744207
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.07665773628744207
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.07665773628744207
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.07665773628744207
HYPERPROLINEMIA, TYPE I	0.000843882	0.07665773628744207
HYPEREKPLEXIA 4; HKPX4	0.000843882	0.07665773628744207
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.07665773628744207
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.07665773628744207
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.07665773628744207
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.07665773628744207
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.07665773628744207
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.07665773628744207
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.07665773628744207
PEHO SYNDROME; PEHO	0.000843882	0.07665773628744207
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000843882	0.07665773628744207
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.07665773628744207
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.07665773628744207
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.000843882	0.07665773628744207
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000843882	0.07665773628744207
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.07665773628744207
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000843882	0.07665773628744207
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.07665773628744207
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.07665773628744207
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.07665773628744207
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000843882	0.07665773628744207
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.07665773628744207
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000843882	0.07665773628744207
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.07665773628744207
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.07665773628744207
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.07665773628744207
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.07665773628744207
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.07665773628744207
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000843882	0.07665773628744207
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000843882	0.07665773628744207
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000843882	0.07665773628744207
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000843882	0.07665773628744207
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.07665773628744207
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000843882	0.07665773628744207
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000843882	0.07665773628744207
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000843882	0.07665773628744207
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.000843882	0.07665773628744207
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.07665773628744207
SULFOCYSTEINURIA	0.000843882	0.07665773628744207
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.07665773628744207
CHROMOSOME 1p35 DELETION SYNDROME	0.000843882	0.07665773628744207
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000843882	0.07665773628744207
CURRARINO SYNDROME	0.000843882	0.07665773628744207
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.07665773628744207
ALAZAMI-YUAN SYNDROME	0.000843882	0.07665773628744207
PELGER-HUET ANOMALY; PHA	0.000843882	0.07665773628744207
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.07665773628744207
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.07665773628744207
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000843882	0.07665773628744207
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000843882	0.07665773628744207
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.07665773628744207
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000843882	0.07665773628744207
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000843882	0.07665773628744207
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.07665773628744207
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.07665773628744207
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 103	0.000843882	0.07665773628744207
CULLER-JONES SYNDROME; CJS	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.07665773628744207
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.07665773628744207
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000843882	0.07665773628744207
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.07665773628744207
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.07665773628744207
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000843882	0.07665773628744207
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.07665773628744207
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000843882	0.07665773628744207
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.07665773628744207
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.07665773628744207
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000843882	0.07665773628744207
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.07665773628744207
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000843882	0.07665773628744207
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000843882	0.07665773628744207
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000843882	0.07665773628744207
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.07665773628744207
ELEJALDE DISEASE	0.000843882	0.07665773628744207
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.07665773628744207
SENIOR-LOKEN SYNDROME 9	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.07665773628744207
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.07665773628744207
Bardet-Biedl syndrome 2	0.000843882	0.07665773628744207
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.07665773628744207
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.07665773628744207
LISSENCEPHALY 8; LIS8	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.07665773628744207
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000843882	0.07665773628744207
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 90	0.000843882	0.07665773628744207
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.07665773628744207
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000843882	0.07665773628744207
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.07665773628744207
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000843882	0.07665773628744207
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000843882	0.07665773628744207
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.07665773628744207
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.07665773628744207
HOLOPROSENCEPHALY 1; HPE1	0.000843882	0.07665773628744207
MUCOLIPIDOSIS IV; ML4	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.07665773628744207
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000843882	0.07665773628744207
EVEN-PLUS SYNDROME	0.000843882	0.07665773628744207
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.07665773628744207
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.07665773628744207
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000843882	0.07665773628744207
Mental retardation, autosomal dominant 21	0.000843882	0.07665773628744207
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000843882	0.07665773628744207
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.07665773628744207
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.07665773628744207
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.07665773628744207
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.07665773628744207
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.07665773628744207
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000843882	0.07665773628744207
CDAGS SYNDROME	0.000843882	0.07665773628744207
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.07665773628744207
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.07665773628744207
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.07665773628744207
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.07665773628744207
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.07665773628744207
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.07665773628744207
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.07665773628744207
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.07665773628744207
KETOADIPICACIDURIA	0.000843882	0.07665773628744207
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.000843882	0.07665773628744207
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000843882	0.07665773628744207
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000843882	0.07665773628744207
WEBB-DATTANI SYNDROME; WEDAS	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.07665773628744207
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000843882	0.07665773628744207
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.07665773628744207
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000843882	0.07665773628744207
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.07665773628744207
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000843882	0.07665773628744207
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.07665773628744207
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.07665773628744207
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000843882	0.07665773628744207
OPTIC ATROPHY 11; OPA11	0.000843882	0.07665773628744207
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.07665773628744207
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000843882	0.07665773628744207
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000843882	0.07665773628744207
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.07665773628744207
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.07665773628744207
JOUBERT SYNDROME 28	0.000843882	0.07665773628744207
GAUCHER DISEASE, TYPE II	0.000843882	0.07665773628744207
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.07665773628744207
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.07665773628744207
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.07665773628744207
BARATELA-SCOTT SYNDROME	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.07665773628744207
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.07665773628744207
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000843882	0.07665773628744207
PHACE ASSOCIATION	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000843882	0.07665773628744207
COACH SYNDROME	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.07665773628744207
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.07665773628744207
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000843882	0.07665773628744207
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.07665773628744207
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000843882	0.07665773628744207
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.07665773628744207
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.07665773628744207
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.07665773628744207
LIG4 SYNDROME	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.07665773628744207
RAHMAN SYNDROME	0.000843882	0.07665773628744207
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000843882	0.07665773628744207
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000843882	0.07665773628744207
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.07665773628744207
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.07665773628744207
BAND HETEROTOPIA; BH	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000843882	0.07665773628744207
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.07665773628744207
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.07665773628744207
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000843882	0.07665773628744207
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.07665773628744207
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.07665773628744207
Cerebral creatine deficiency syndrome 3	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000843882	0.07665773628744207
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000843882	0.07665773628744207
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.07665773628744207
JOUBERT SYNDROME 30; JBTS30	0.000843882	0.07665773628744207
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.07665773628744207
OROTIC ACIDURIA	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.07665773628744207
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000843882	0.07665773628744207
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000843882	0.07665773628744207
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.07665773628744207
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000843882	0.07665773628744207
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000843882	0.07665773628744207
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.07665773628744207
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.07665773628744207
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000843882	0.07665773628744207
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.07665773628744207
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.07665773628744207
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.07665773628744207
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000843882	0.07665773628744207
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.07665773628744207
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.07665773628744207
CHROMOSOME 2q37 DELETION SYNDROME	0.000843882	0.07665773628744207
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.07665773628744207
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.07665773628744207
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000843882	0.07665773628744207
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000843882	0.07665773628744207
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.000843882	0.07665773628744207
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.07665773628744207
#300555 DENT DISEASE 2	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.07665773628744207
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.07665773628744207
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000843882	0.07665773628744207
PELLAGRA-LIKE SYNDROME	0.000843882	0.07665773628744207
HOLOPROSENCEPHALY 11	0.000843882	0.07665773628744207
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.07665773628744207
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.07665773628744207
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.07665773628744207
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.07665773628744207
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000843882	0.07665773628744207
SEPTOOPTIC DYSPLASIA	0.000843882	0.07665773628744207
LISSENCEPHALY 4	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.000843882	0.07665773628744207
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000843882	0.07665773628744207
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.07665773628744207
PELIZAEUS-MERZBACHER DISEASE	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000843882	0.07665773628744207
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 1; BBS1	0.000843882	0.07665773628744207
JOUBERT SYNDROME 25	0.000843882	0.07665773628744207
CHOPS SYNDROME; CHOPS	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.07665773628744207
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000843882	0.07665773628744207
JOUBERT SYNDROME 6	0.000843882	0.07665773628744207
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000843882	0.07665773628744207
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.07665773628744207
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.07665773628744207
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.07665773628744207
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.07665773628744207
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.07665773628744207
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000843882	0.07665773628744207
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.07665773628744207
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.07665773628744207
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.07665773628744207
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000843882	0.07665773628744207
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.07665773628744207
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000843882	0.07665773628744207
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000843882	0.07665773628744207
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.07665773628744207
Leukotriene C4 synthase deficiency	0.000843882	0.07665773628744207
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000843882	0.07665773628744207
TIMOTHY SYNDROME; TS	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.000843882	0.07665773628744207
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000843882	0.07665773628744207
HURLER SYNDROME	0.000843882	0.07665773628744207
ADAMS-OLIVER SYNDROME 1; AOS1	0.000843882	0.07665773628744207
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.07665773628744207
COFFIN-SIRIS SYNDROME 5	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000843882	0.07665773628744207
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.07665773628744207
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.000843882	0.07665773628744207
AUSTRALIA ANTIGEN	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.07665773628744207
PHELAN-MCDERMID SYNDROME; PHMDS	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000843882	0.07665773628744207
JOUBERT SYNDROME 8	0.000843882	0.07665773628744207
COFFIN-SIRIS SYNDROME 2; CSS2	0.000843882	0.07665773628744207
SCHINDLER DISEASE, TYPE I	0.000843882	0.07665773628744207
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.07665773628744207
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.07665773628744207
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000843882	0.07665773628744207
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000843882	0.07665773628744207
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.000843882	0.07665773628744207
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.07665773628744207
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.07665773628744207
MICROPHTHALMIA, SYNDROMIC 3	0.000843882	0.07665773628744207
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000843882	0.07665773628744207
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000843882	0.07665773628744207
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000843882	0.07665773628744207
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000843882	0.07665773628744207
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.000843882	0.07665773628744207
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.07665773628744207
LOWRY-MACLEAN SYNDROME	0.000843882	0.07665773628744207
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.07665773628744207
Temtamy preaxial brachydactyly syndrome	0.000843882	0.07665773628744207
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.07665773628744207
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.07665773628744207
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000843882	0.07665773628744207
ARGININOSUCCINIC ACIDURIA	0.000843882	0.07665773628744207
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.07665773628744207
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000843882	0.07665773628744207
HARTNUP DISORDER	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000843882	0.07665773628744207
LANDAU-KLEFFNER SYNDROME	0.000843882	0.07665773628744207
JOUBERT SYNDROME 26	0.000843882	0.07665773628744207
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.07665773628744207
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.000843882	0.07665773628744207
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.07665773628744207
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000843882	0.07665773628744207
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000843882	0.07665773628744207
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.07665773628744207
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000843882	0.07665773628744207
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.07665773628744207
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.07665773628744207
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.07665773628744207
JOUBERT SYNDROME 27	0.000843882	0.07665773628744207
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.07665773628744207
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.07665773628744207
AICARDI-GOUTIERES SYNDROME 7	0.000843882	0.07665773628744207
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000843882	0.07665773628744207
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000843882	0.07665773628744207
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000843882	0.07665773628744207
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.07665773628744207
WAISMAN SYNDROME; WSMN	0.000843882	0.07665773628744207
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.07665773628744207
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000843882	0.07665773628744207
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.07665773628744207
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000843882	0.07665773628744207
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.07665773628744207
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000843882	0.07665773628744207
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.07665773628744207
Jawad syndrome	0.000843882	0.07665773628744207
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.07665773628744207
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000843882	0.07665773628744207
HOLOPROSENCEPHALY 7	0.000843882	0.07665773628744207
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.000843882	0.07665773628744207
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000843882	0.07665773628744207
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.07665773628744207
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.07665773628744207
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.07665773628744207
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000843882	0.07665773628744207
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.000843882	0.07665773628744207
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000843882	0.07665773628744207
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.07665773628744207
JOUBERT SYNDROME 15	0.000843882	0.07665773628744207
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.07665773628744207
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000843882	0.07665773628744207
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.07665773628744207
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000843882	0.07665773628744207
LISSENCEPHALY 1; LIS1	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.07665773628744207
